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Cellular and biochemical studies support a role for all five human RecQ helicases in DNA 
replication, however their specific functions during this process are unclear. In my 
thesis, I investigated the in vivo association of the five human RecQ helicases with three 
well-characterized human replication origins. I showed that only RECQ1 and RECQ4 
associate with replication origins in a cell cycle-regulated fashion in unperturbed cells, 
while other RecQ helicases interact with replication origins only under replication 
perturbed conditions. Under endogenous conditions, RECQ4 is recruited to origins at 
late G1 after ORC and MCM complex assembly, while RECQ1 and additional RECQ4 are 
loaded at origins at the onset of S phase when licensed origins begin firing. Both 
proteins are lost from origins after DNA replication initiation, indicating either 
disassembly or tracking with the newly formed replisome. Cell proliferation, DNA 
synthesis, nascent origin DNA synthesis and the frequency of origin firing are reduced 
after RECQ1 depletion, and to a greater extent after RECQ4 depletion. Depletion of 
RECQ1, though not RECQ4, also suppresses replication fork rates in otherwise 
unperturbed cells. Loading of PCNA during S phase is affected by RECQ1 depletion while 
the RECQ4 depleted cells show defect in RPA and PCNA loading during S phase of the 
cell cycle. These results indicate that RECQ1 and RECQ4 are integral components of the 
human replication complex, and play distinct roles in DNA replication initiation and 






The nucleus is an essential organelle of the mammalian cell which hosts the genome of 
an organism. Each genome replicates, transcribes, and expresses its genetic information. 
The DNA present in the genome is in the double stranded form. However, for many 
important DNA transactions, such as replication, repair, recombination, and in some 
cases transcriptions, the duplex DNA has to be partially unwound for a short time to 
create single stranded DNA intermediates, through which some of the proteins 
responsible for the above mentioned processes can load on the DNA. A class of 
enzymes, called DNA helicases, catalyzes the transient unwinding of duplex DNA in an 
adenosine triphosphate (ATP)-dependent manner and play an essential role in all 
aspects of DNA metabolism. DNA helicases are processive molecular motors which 
utilize chemical energy from nucleoside triphosphate (NTP) hydrolysis to translocate 
along the single stranded DNA. The importance of DNA helicases in cellular processes is 
underlined by the numerous human diseases like Xeroderma pigmentosum, Cockayne 
syndrome or Trichothiodystrophy, Bloom syndrome, Werner syndrome, and Rothmund-
Thomson syndrome that are associated with defective helicases (Ellis, 1997; Matson et 
al., 1994; Mohaghegh and Hickson, 2001; von Hippel, 2004).   
Classification of DNA helicases 
The DNA helicases are classified based on their conservation of characteristic amino acid 
sequences (helicases motifs) and by their direction of translocation along nucleic acid 
substrates (West, 1996). At the sequence level, based on the presence of different 
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‘signature motifs,’ DNA helicases have been divided into six main groups (Singleton et 
al., 2007) (figure 1.1, table 1.1), the largest being superfamily
 
I and II (SF1 and SF2) 
helicases. Both SF1 and SF2 helicases contain seven conserved helicase motifs,
 
I, Ia, II, III, 
IV, V, and VI. Motifs
 
I and II are the highly conserved Walker A and B sequences 
characteristic
 
of ATPases. The other motifs are generally less conserved and differ 
between the SF1 and SF2 proteins. PcrA from Bacillus stearothermophilus and NS3 from 
hepatitis C virus are probably the best characterized SF1 and SF2 proteins, respectively 
(Kim et al., 1998; Velankar et al., 1999). SF3 enzymes are
 
usually from DNA or RNA 
viruses and contain only four conserved
 
motifs termed A, B, B’, and C. The A and B 
motifs correspond to Walker A and Walker B sequences, whereas motif C is SF3 specific. 
BPV E1 is a good example of SF3 proteins (Hickman and Dyda, 2005). SF4 helicases 
contain five conserved motifs, H1, H1a, H2, H3, and H4. The H1 and H2 motifs 
correspond to Walker A and Walker B sequences, whereas H1a, H3 and H4 motifs are 
specific to SF4 helicases. T7 gp4D protein belongs to SF4 helicases (Singleton et al., 
2000). SF5 helicases contains enzymes such as the
 
bacterial transcription termination 
factor Rho with three conserved motifs 1, 1a ,and 2, while SF6 helicases contain four 
conserved motifs A, B, S1 and S2. SF6 helicases are also known as  AAA
+
 family - ATPases 
associated with various cellular activities. RuvB from T.maritima is an example of an SF6 
helicase that has been crystallized and characterized(Singleton et al., 2007). 
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Figure 1.1 : Classification of DNA helicases based on conserved aminoacid sequences.The name of one 
representative member of each of the six superfamilies is given in parentheses. The domains and the 
positions of the signature motifs therein are shown for each class of helicase. Precise position of each 
motif is based on the example family member and is representative for the whole family. Motifs colored 
yellow represent universal structural elements in all helicases. The positions and functions of accessory 




          DNA Helicases can be also  classified  based on the direction of translocation along 
the nucleic acid substrate. The in vitro experiments using partial DNA duplex substrates 
with a linear single strand DNA (ssDNA) tail have shown that helicases can translocate 
either 3’ to 5’ or 5’ to 3’ along ssDNA, in respect to the binding strand (Figure1.2). SF1 
and SF2 helicases contain examples of helicases with 3’ to 5’ and 5’ to 3’ processivity. All 
characterized SF3 helicases show 3’ to 5’ activity, whereas SF4 and SF5 helicases show 5’ 
to 3’ activity. SF6 helicases contains examples of both 3’ to 5’ and 5’ to 3’ processivity 




Figure 1.2 : Structures of the partial duplex substrates commonly used to determine the direction of 
translocation of the helicase. The 3’ to 5’ directional substrates are on the left and 5’ to 3’ directional 






Table 1: Classification of DNA helicases. DNA helicases superfamily are_shown with respective 
characteristics and examples. 
 
1.2  Functional mechanism of DNA helicases 
DNA helicases have two important activites: unwinding the duplex nucleic acids and 
translocating along the ssDNA. The existence of mutants that show no defect in either 
nucleic acid (NA) binding or NTP binding and hydrolysis activities, but with impaired 
double stranded DNA (dsDNA) unwinding activities, confirms that NA binding and NTP 
hydrolysis must be coupled. The mechanism by which the helicases couple their 
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translocation along a single stranded nucleic acid to the unwinding of a double stranded 
nucleic acid is unclear. Two competing mechanisms known as the inchworm mechanism 
and active rolling mechanism have been a subject of debate during the past few years. 
         The inchworm model has been proposed for monomeric helicases. A cycle of DNA 
binding, release, and translocation events begins with one helicase site bound tightly to 
the DNA and the second helicase site bound weakly to the DNA. The weak site 
dissociates from the DNA and in a power stroke motion moves away from the tight site 
to bind at a position ahead. After the weak site has moved and made tight interactions 
ahead, the original tight site becomes weak, and, as it dissociates from the DNA, in a 
power stroke motion it moves forward to get close in distance to the site ahead (fig 1.3). 
The crystal structures of a B. stearothermophilus PcrA monomer in complex with a 3’-
(dN)7  – 10 bp dsDNA  helped to propose an inchworm type stepping model for a 
monomeric helicase. The crystal structures of E.coli UvrD monomer proved to be 
another good example of the inchworm model (Lee and Yang, 2006; Velankar et al., 
1999). 
                    The active rolling model has been proposed for dimeric helicases. In this 
model, each of the two subunits of the helicase alternate their binding to single-
stranded and duplex DNA as they change their NTP ligation states. In contrast to the 
inchworm model, where the subunits maintain their relative positioning along the DNA, 
the subunits in the rolling model take turn in being the trailing or the leading subunit. X-
ray structures of two forms of Rep helicase (open and closed forms) bound to a short 
piece of ssDNA and the structure of a ternary complex containing both ssDNA and 
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adenosine diphosphate (ADP) helped to propose the active rolling model (Korolev et al., 
1997; Waksman et al., 2000).  
 
       
 
 
Figure 1.3: Models for DNA helicase translocation and unwinding. (A) Inchworm model, involves two 
binding sites, a single and a double-stranded DNA binding site, either belonging to a single monomeric 
enzyme (inch-worm monomeric enzyme, D. B. Wigley), or present on two different subunits of a dimeric 
enzyme (inchworm dimeric enzyme, T. M. Lohman).(B) Active rolling model, involves two subunits of a 





1.3 Functional forms of DNA helicases 
DNA helicases exists in different oligomeric forms. Previous studies have shown that  
some of these enzymes are monomers, while other form dimers or higher-order 
oligomers. DNA helicases are functionally activated/regulated by their assembly state. 
However, the assembly state responsible for the “ functionally active” DNA helicases 
differs within the helicase family itself. Pre-steady – state kinetic analysis has shown that 
helicases like T4 Dda, HCV NS3h and E.coli RecQ could function as monomers (Dou et al., 
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2004; Nanduri et al., 2002; Xu et al., 2003). A recent study based on fluorescence cross-
correlation spectroscopy has shown that E.coli RecQ monomers are sufficient to 
perform the unwinding of short DNA substrates and binding of multiple helicase 
monomers are required to unwind long DNA substrates (Li et al.). Some helicases need a 
structural interaction to form homodimers (UvrD) or heterodimers (RecBCD) in order to 
be functionally active. The different assembly states of DNA helicases are shown in the 
figure 1.4. The assembly state can also regulate different functions as in the case of 
human RECQ1 helicases in which monomers or dimers perform unwinding while higher 
order oligomers perform annealing (Muzzolini et al., 2007). 
 
 
Figure  1.4: Assembly states of DNA helicases. Three possible helicase quaternary structures that makes 
DNA helicases functionally active. (a) A homodimer, (b) A monomeric protein or a multi-protein complex 





2. RecQ helicases 
The RECQ protein family is a highly conserved group of SF2 DNA helicases that have 
been identified in organisms ranging from bacteria to humans. The prototypical member 
of the family, RecQ of Escherichia coli, was identified in a study aimed at clarifying the 
mechanism of thymineless death, a phenomenon underlying the mechanism for the 
cytotoxicity of the anticancer drug 5-fluorouracil (Nakayama et al., 1984). Unicellular 
organisms contain only one representative of the family, such as E.coli RecQ and 
Saccharomyces cerevisiae Sgs1, while numbers of RecQ genes vary from species to 
species in multicellular organisms. For example, fruit flies (Drosophila melanogaster) 
and vertebrates have three and five RecQ genes, respectively 
(Bennett et al., 1998; Gray et al., 1997; Karow et al., 1997). Human cells express at least 
five members; RECQ1, BLM, WRN, RECQ4, and RECQ5 (Figure 2.1). All the RecQ 
helicases studied so far have been found to unwind DNA with a  3’- 5’ polarity. 
The RecQ helicases are characterized by the conserved helicase domain, the RecQ C-
terminal domain (RQC), and the Helicase RNaseD C-terminus (HRDC) domain. The 
helicase domain is present in all RecQ family proteins, while RQC and HRDC are missing 
in some representatives of RecQ family. Helicase domain is important for NTP binding 
and nucleic acid unwinding, while the RQC domain, which is unique to RecQ helicases, is 
also important in mediating protein-protein interactions. The less conserved HRDC 
domain assists in recognizing DNA substrates. Nuclear localization signals (NLS) have 
been identified at the C-terminal end of RECQ1, BLM, and WRN. N-terminal extensions 
of approximately 600 amino acids that contain regions rich in acidic amino acids have 
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been identified in Sgs1p, Rqh1, BLM, WRN, and RECQL4. In addtion, WNR is 
characterized by the presence of a exonuclease domain at the N-terminus 
(Vindigni and Hickson, 2009). 
In humans, defects in three RecQ family proteins are associated with rare autosomal 
recessive disorders characterized by genomic instability and increased cancer 
susceptibility. Mutations in WRN, BLM, and RECQ4 give rise to the disorders Werner 
syndrome (WS), Bloom syndrome (BS), and Rothmund-Thomson syndrome(RTS), 
respectively (Ellis et al. 1995, Yu et al.1996, Kitao et al.1999). The clinical features of 
these disorders differ for each syndrome. Briefly, BS patients are predisposed to many 
types of cancer with the mean age of onset of 24. WS patients are especially 
predisposed to sarcomas, premature aging, and age- associated diseases. RTS patients 
have a characteristic rash, poikiloderma, and are predisposed to osteosarcomas and 
some features of premature aging.  
In vitro biochemical experiments combined with knock out strategies and with the 
inference from patients with mutated RecQ genes, have shown that RecQ helicases play 
a key role in protecting and stabilizing the genome. RecQ helicases have been shown to 
participate in DNA replication, recombination, repair and in cell cycle control events. 
Deficiencies in RecQ helicases can lead to high levels of genomic instability and to 
premature aging and increased susceptibility to cancer. These diverse cellular functions 
support the notion that the RecQ helicases are guardians of the genome 






             
 
Figure 2.1: Schematic representation of the RecQ helicases of selected organisms. The family is named 
after the bacterial (Escherichia coli) DNA helicase RecQ. Family members have been also identified in 
fission yeast (Rqh1p), budding yeast (Sgs1p), flies (DmBLM, DmRECQ5β, DmRECQ4), ), amphibians (FFA-1, 
xBLM, xRECQ4) and humans (WRN, BLM, RECQ4, RECQ1, RECQ5β.  Proteins are aligned by their conserved 
helicase domains (brown boxes). At least three splice variants of the human RECQ5 protein are expressed, 




2.1  BLM helicase 
The Bloom syndrome helicase (BLM) is a DNA helicase of 1417 amino acid residues 
(Karow et al., 1997). Positional cloning experiments revealed that the BLM helicase is 
encoded by the locus for Bloom syndrome at 15q26.1 and it contains amino acid motifs 
that are homologous to motifs present in other RecQ helicases (Ellis et al., 1995). The 
BLM helicase is expressed in all the tissues, however it shows a high expression pattern 
in testis and ovary. At cellular level the BLM helicase is expressed during the S and G2  
phases of the cell cycle and  it is localized in the nucleus of human cells within discrete 
foci termed promyelocytic leukemia (PML) nuclear bodies (Ababou et al., 2000; Dutertre 
et al., 2000; Gharibyan and Youssoufian, 1999). Defects in the blm gene are the cause of 
Bloom Syndrome (BS) (Ellis et al., 1995). 
 
2.1.1 Clinical manifestations of BLM deficiency 
A) Bloom syndrome patients 
BS is a rare autosomal recessive disorder and persons with BS are characterized by 
proportionate pre- and postnatal growth deficiency, sun-sensitive telangiectatic hypo- 
and hyper-pigmented skin, immune deficiency, predisposition to malignancy and 
chromosomal instability (Figure 2.2). BS patients also show a very high incidence of 




                                      
         Figure 2.2: A Bloom syndrome patient showing sun sensitive telangiectatic erythema. 
 
B) Murine model 
Four BS mice models have been generated. Mice in which part of the blm gene 
upstream of the helicase domain is replaced with neomycin resistance cassette showed 
growth defect and micronuclei similar to human BS patients(Chester et al., 1998). The 
second mice in which exons 10–12 were replaced with HPRT (hypoxanthine–guanine 
phosphoribosyltransferase) showed a slight increase in the frequency of micronuclei 
(Goss et al., 2002). However, both knockout mice had a short life span. Given the fact 
that BLM is not essential for viability in humans, Allan Bradley’s group generated two 
more knockout models by replacing exon 2 using an Embryonic stem cell (ES) method. 
The first mice again showed lethality. However, the second mice where integrated 
vector sequences were removed, gave rise to viable homozygous mutant mice. These 
mice served as better model and closely recapitulated the cellular phenotype of Bloom 






Cells from patients with BS and the cells derived from Blm knockout mice exhibit 
chromosome instability. Particularly BS patient’s cell showed increased numbers of 
chromatid gaps, breaks, chromosome structural rearrangements and sister chromatid 
exchanges (SCE). It has been reported that BS cells as well as BLM-/+  fibroblasts show a 
tendency for the accumulation of micronuclei (Frorath et al., 1984; Rosin and German, 
1985). Moreover, these cells display a significantly lower rate of chain elongation during 
DNA synthesis (Hand and German, 1975). In addition, BS cells are sensitive to UV 
radiation and hydroxyurea (HU) (Ababou et al., 2002a). Blm deficient mouse embryonic 
fibroblast (MEF) cells showed elevated mitotic recombinations with the increased SCE 
(Luo et al., 2000). Such elevated level of chromosal disruptions observed in BS cells and 
Blm deficient MEF cells could likely be the reason for high incidence of cancer in Bloom 
Syndrome patients.  
 
2.1.2  Structural aspects of BLM protein 
A) Domain architecture  
 
The BLM helicase consists of seven domains. Starting from the amino terminus, these 
domains are the poly-aspartate domain (PD1), the poly-serine domain (PS), the poly-
aspartate domain (PD2), the DEAH helicase domain (DEAH), the RecQCt, the HRDC, and 
the NLS. The C-terminal domain is essential for the strand annealing activity of BLM 
(Cheok et al., 2005). Although many BS mutations truncate the BLM protein upstream of 
helicase domain, four single amino acid substitutions in helicase domain namely Q672R, 
I841T, G891E, C901Y, and three point mutations, K703A, Q680P, and I849T have been 
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reported in the human BLM and in the mouse BLM, respectively (Figure 2.3). The above 
mentioned substitutions and point mutations abolish both ATPase and DNA unwinding 
activities of the BLM protein (Rong et al., 2000). 
 
       
 
Figure  2.3 : Schematic depiction of  wild-type human BLM protein with characterised mutations.  
 
B) Assembly state 
Different assembly states have been reported for the BLM protein. Electron microscopy 
and size exclusion chromatography analysis have shown that the full-length BLM protein 
forms ring-like oligomers in the absence of ATP and DNA, and the higher oligomeric 
state is responsible DNA strand annealing activity (Cheok et al., 2005). Interestingly, 
biochemical studies with the deletion mutant BLM 
642-1290
 revealed that monomers are 








2.1.3 Biochemical characteristics of the BLM protein 
A) Enzymatic activities   
BLM helicase is an ATP- and Mg
2+ 
dependent enzyme that unwinds DNA with a 3’ to 5’ 





but it is inhibited by ssDNA binding
 
proteins and ATP. In addition, the 
annealing activity is regulated by the length of the DNA (Cheok et al., 2005). 
Apart from conventional fork like structures, BLM helicases can unwind linear duplexes, 
mobile holliday junctions, G4-DNA, G2-DNA, RNA:DNA hetero duplexes, R-loops, D-loops 
and model stalled replication forks (Popuri et al., 2008). 
 
2.1.4 Functional role of the BLM protein 
BLM helicase plays a vital role in regulating recombination events. The suppression role 
of BLM in recombination is evident by the hyper-recombination phenotype of BS patient 
cells and of cells derived from Blm knockout mice. This increased recombination events 
is connected to the tumour susceptibility in Blm knocout mice (Stenner-Liewen et al., 
2000). BLM together with the hTOPO III, RMI1, and RMI2 complex can also process 
recombination intermediates that contain double Holliday junctions into noncrossover 
products by a mechanism known as dissolution of Holliday junctions (Wu et al., 2006). In 
addition, BLM has been shown to participate in various DNA double strand break repair 
pathways by regulating homologus recombination events. BLM has also been shown to 
participate in cellular response pathways to ionizing radiations by acting as an ATM 
kinase downstream effector (Ababou et al., 2000).  
17 
 
        Most importantly, BLM’s role in DNA replication is well documented. The hyper 
sensitivity of BS cells and BLM knockout MEF cells to replication inhibitors  (Ababou et 
al., 2002a, b), the blocked S phase progression in HU treated BS cells (Davies et al., 
2004), and the stalled replication forks observed in HU treated BS cells (Davies et al., 
2007) support a role of BLM role in replication fork restart. Mechanistically, BLM was 
suggested to restart replication forks by transporting p53 to RAD51 sites at the stalled 
replication forks (Sengupta et al., 2003). In addition, to fork restart BLM has also shown 
to suppress origin firing during replication stress (Davies et al., 2007).  
 
2.1.5 Regulation of BLM function 
A) Post translational modifications 
At least two post translational modifications have been reported for the BLM helicase. 
The BLM helicase appear to be phosphorylated during mitosis and during replication 
insults. The ATM kinase phosphorylates the BLM protein and the phosphorylated form 
loses its association with the nuclear matrix, and it is found preferentially in the 
nucleoplasmic fraction. This observation suggests that phosphorylation might assist BLM 
to the sites of DNA damage, thus helping in DNA repair or recombination (Beamish et 
al., 2002; Dutertre et al., 2000). 
                 BLM helicase is also reported to be “sumoylated” and it has been 
demonstrated that sumoylated BLM resides in PML-NBs suggesting that sumoylation 





B) Protein protein interactions 
Several proteins that are involved in different DNA metabolic pathways have been 
reported to interact with BLM. Weidong Wang lab has reported the presence of BLM in 
at least three multiprotein complexes in HeLa cells (Meetei et al., 2003). 
Fanconi’s anemia proteins (FA) , Replication Protein A (RPA), and MLH1 are components 
of some of these complexes (Meetei et al., 2005; Meetei et al., 2003), Two proteins are 
present in all BLM associated complexes: Topo 3α, and a protein first named as BLAP75 
(Yin et al., 2005), but later renamed RMI1 (RecQ-mediated genome instability) (Wu et al. 
2006). RMI1 contains an oligonucleotide-binding (OB)-fold domain (Yin et al. 2005), and 
regulates BLM function by interacting with BLM and TOP3α. This complex specifically 
“dissolves” the Holliday junctions that arise during double strand break repair. Evidence 
from both human and yeast studies suggests that BLM (or its ortholog Sgs1), Topo 3α, 
and RMI1 form an evolutionarily conserved complex that works coordinately to process 
a diverse array of DNA structures in eukaryotes (Raynard et al., 2006; Wu et al., 2006; Xu 
et al., 2008; Yin et al., 2005) (Figure 2.4). Interestingly, RPA has shown to increase the 
processivilty of the BLM catalysed DNA unwinding activity by interacting with the BLM 
protein. Conversely, BLM interaction with FA complex proteins resolves the interstrand 
crosslinks of DNA. BLM also interacts with p53 and RAD51, and  these interactions 
regulate the localization of BLM during homologous recombination repair in replication 
insulted cells (Bischof et al., 2001; Wu et al., 2001; Sengupta et al., 2003). Moreover, the 
interaction of BLM with MLH1 was suggested to regulate the mismatch repair process 







Figure 2.4 : Potential roles of BLM and its interaction partners in human cells. Schematic diagram 
indicating alternative pathways for the repair of stalled replication forks that arise as a result of DNA 
damage. Picture adopted from (Liu and West, 2008). 
 
 
 2.1 WRN helicases  
 The WRN helicase is a DNA helicase and exonuclease of 1432  amino acid residues. 
Positional cloning experiments revealed that the WRN helicase is encoded by the locus 
for Werner syndrome at p11-p12 region of chromosome 8, encompassing 180 kb 
(Matsumoto et al., 1997; Yu et al., 1996). Sequence homology marks WRN as a member 
of the RecQ family of DNA helicases. WRN is highly expressed in the testis, ovary and 
pancreas with a cell cycle regulated expression that  peaks during the G2 /M  phases 
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(Kitao et al., 1998). WRN is localized in the nucleus of human cells within discrete foci 
termed promyelocytic leukemia (PML) nuclear bodies (Ababou et al., 2000; Dutertre et 
al., 2000; Gharibyan and Youssoufian, 1999). Importantly, defects in the wrn gene are 
found to be the cause of Werner Syndrome (WS)  (Ellis, Groden et al., 1995). 
 
2.2.1 Clinical manifestations of WRN deficiency  
A) Werner syndrome patients 
Werner syndrome is an autosomal recessive condition characterized by an early onset of 
age-related symptoms that include ocular cataracts, premature graying and loss of hair, 
arteriosclerosis and atherosclerosis, diabetes mellitus, osteoporosis, and a high 
incidence of cancers. The predominant cancers in WS are soft-tissue sarcoma, 
osteosarcoma, myeloid disorders, thyroid cancer, and benign meningiomas (Figure 2.5). 
                                 
Figure 2.5: A Werner syndrome patient showing ageing phenotype. 
 
B) Murine model 
Two WS mice model have been generated so far. The first mice, where exons that 
encode motifs III and IV of the helicase domain were targeted, shared phenotypes 
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similar to those of human WS patients. Similar to WS patients, the knockout mice 
acquired myocardial fibrosis, T cell lymphoma, and were prone to cancer (Lebel and 
Leder, 1998). The second mice with
 
a mutation that eliminates expression of the C 
terminus of the
 
helicase domain din’t show any organismal phenotype that resembles 
WS patients. However, p53−/− WRN−/− double-knockout mice died earlier and the lack 
of p53 accelerated the mortality of WRN−/− or WRN−/+mice (Lebel et al., 2001; 
Lombard et al., 2000). 
C) Cellular phenotype 
Primary Cells from WS patients undergo replicative senescence more rapidly than 
normal cells and are highly sensitive to cross linking agents, especially to 4-
nitroquinoline 1-oxide (4-NQO). They also lose their proliferative capacity at an 
accelerated rate. Additionaly, cultured fibroblasts from such patients have an extended 
S phase of the cell cycle (Salk et al., 1981). Telomere dysfunction likely contributes the 
premature senescence because, serially passaged Werner
 
syndrome fibroblasts shorten 
telomeres more rapidly than controls
 
and senesce prematurely. The expression of 
telomerase hTERT in WS cells leads to the immortalization of cells and reduces their 
sensitivity towards cross linking agents (Choi et al., 2001; Salk et al., 1981). At 
chromosome level, the cells carry increased number of chromosomal translocations and 
deletions. Such chromosomal aberrations observed in WS cells and WRN deficient MEF 






2.2.2 Structural aspects of WRN protein 
A) Domain architecture  
 
WRN contains four major domains comprising an exonuclease, a helicase, a RecQCt, and 
a HRDC domain. The 3'-5' exonuclease region of the protein is 171 amino acids long and 
is located at the N-terminal end of the protein. It is highly similar to the exonuclease 
regions of other proteins such as the DNA polymerases that have DNA proofreading 
activity. When exposed to double stranded DNA, the exonuclease domain forms a 
hexamer around the end of the strand and remove bases toward the 5' end. This region 
is essential to the DNA repair function of WRN  (Xue et. al., 2001). Kitano et al reported 
the crystal structure of the human WRN HRDC domain. They demonstrated that HRDC 
domain forms a bundle of α-helices and has a novel looping motif.Moreover, the same 
authors showed that this domain is thermostable and resistant to protease digestion 
(Kitano et al., 2007). The HRDC domain consists of 80 amino acids at the C-terminal end 
of the protein. It contains five helices connected by short turns or hydrophobic loops. 
Certain hydrophobic residues within the loops are necessary for the packing of this 
domain into a bundle. A patch near helix a4 has been shown to interact with DNA in a 
non-sequence specific manner, suggesting that this domain may contribute to the 
interaction between the WRN protein and the double stranded DNA (Liu et. al., 1999). 
The RQC domain has also been crystallized. The crystal structure of the WRN RQC-DNA 
complex represented the first DNA bound structure of a RecQ family member and 
revealed that the winged-helix motif acts as a strand separating knife during the 
unwinding reaction ( Kitano et al., 2009). 
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Although mutations throughout the wrn gene have been observed
 
in the homozygous 
state, homozygosity for a mutation very near
 
the 3' end of the wrn open reading frame 
is sufficient to lead
 
to the WS (Figure 2.6). Some of the mutant WRN proteins from WS 
patients lack the nuclear localization element, thus they are not translocated to the 
nucleus. Interestingly, mice bearing
 
a targeted mutation in the catalytic helicase domain 
of wrn are
 
viable and fertile revealing that mutations in helicase domains are not 




Figure 2.6 : Schematic depiction of  wild-type WRN protein with location of few mutations that could 
contribute to WS. Figure drawn based on Prof. Raymond Monnat lab webpage information. Ref : 
http://www.pathology.washington.edu/research/werner/database/ 
 
C) Assembly state  
 
The assembly states of full length WRN as well as of some fragments of WRN have been 
characterized. Gel filteration chromatography and atomic force microscopy analysis 
showed that exonuclease fragment of WRN forms hexamers. Consistently biochemical 
data obtained with recombinant N-terminal WRN fragments and full-length WRN 
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suggest oligomerization (possibly trimeric) of WRN in vivo (Huang et al., 2000; Xue et al., 
2002). WRN trimers may provide the necessary quaternary structure for interaction with 
PCNA. However, recent electron microscopy studies indicated that WRN binds to 
replication fork like structure and HJ as a tetramer (Perry et al., 2006) suggesting that 
tetramer formation might enhance WRN exonuclease and/or helicase activities. 
 
2.2.3 Biochemical characteristics of the WRN protein 
A) Enzymatic properties   
The WRN helicase is an ATP- and Mg
2+
-dependent enzyms that unwind DNA with a 3’ to 
5’ polarity with poor processivity. WRN can also promote the single-stranded DNA 
(ssDNA) annealing and possess a characteristic 3’-5’ exonuclease activity (Orren et al., 
2002). The WRN helicase coordinates its helicase and exonuclease activities to unwind 
model fork DNA. WRN degrades the 3′ recessed strands of double-stranded DNA or a 
DNA–RNA heteroduplex and efficiently removes a mismatched nucleotide at a 3′ 
recessed terminus. It can unwind bubble substrates, bubble-containing double stranded 
DNA, DNA with a single stranded loop, and G-quadruplex DNA. In addition, WRN can 
branch migrate Holliday junctions (Mohaghegh et al., 2001). 
 
2.2.4 Functional role of WRN protein 
The primary function of Werner helicase can considered to be at telomeres on the basis 
of the reports that show defective replication of G-rich telomeric DNA in WS cells 
(Crabbe et al., 2007; Crabbe et al., 2004), cellular senescence phenotype of WS cells and 
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WRN knockout MEF, ageing phenotype of WS patients (Davis et al., 2007; Fukuchi et al., 
1989), (Davis et al., 2007; Fukuchi et al., 1989), and on the basis of the molecular 
analysis showing a functional interaction of WRN with TRF (Multani and Chang, 2007).  
Like BLM, WRN was also shown to participate in DNA replication. The efficient removal 
of a terminal mismatched nucleotide raises the possibility that WRN may provide 3′→5′ 
proofreading activity for DNA polymerases that lack such activity. In line with these 
findings, WS cells are known to be hypermutable, accumulating cytogenetic 
abnormalities consistent with deletions and rearrangements. Additionaly, WRN is 
homologous to FFA-1, a Xenopus laevis protein required for replication focus formation 
during DNA replication. In addition, the finding that WRN interacts with PCNA support 
the notion that WRN may function in DNA replication. In line with these observations, 
WRN has been
 
proposed to reset reversed forks or other replication intermediates
 
arising after fork stalling (Khakhar et al., 2003). Alternatively,
 
WRN has also been 
implicated in the resolution of recombination intermediates
 
arising after RAD51-
dependent strand invasion (Saintigny et al., 2002). Additional studies have shown that 
WRN promotes rRNA transcription (Shiratori et al., 2002) and stimulates DNA 
polymerase δ (Lebel et al., 1999). WRN has also been reported to participate in several 
DNA repair pathways.  Mismatch repair involves an incision on the damaged DNA strand 
followed by removal by an exonuclease. WRN can potentially fulfill the exonuclease 
requirement in this process. In line with it, SV40-transformed WS cells are deficient in 
mismatch repair (Saydam et al., 2007). However, WRN may also participate in the repair 
of other types of DNA damage such as interstrand crosslinks (ICL) mediated DNA 
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damages as WS cells are hypersensitive to 4NQO, which leads to elevated rates of 
chromosome breaks and exchanges (Ogburn et al., 1997).  
Moreover, WRN was also shown to participate in long patch base excision repair (BER) 
by cooperating with pol β (Harrigan et al., 2006). 
 
2.2.5 Regulation of the WRN protein function 
A) Post-translational modifications of WRN 
WRN is acetylated in a DNA damage dependent manner by p300 acetyltransferase and 
this acetylation helps the WRN helicase to localize in nucleoplasmic fraction (Blander et 
al., 2002). A recent report from Bohr’s group suggests that WRN function during Base 
Excision Repair (BER) is regulated by acetylation. The WRN helicase is also 
phosphorylated upon treatment with DNA damaging agents and, in contrast to 
acetylation, phosphorylation inhibits its helicase and exonuclease activities (Yannone et 
al., 2001). Pichierri et al have shown that WRN is phosphorylated in an ATR/ATM 
dependent manner following replication arrest (Pichierri et al., 2003). Additionaly, WRN 
is sumoylated in vivo. WRN helicase interacts and co-localize with SUMO-1 (small 
ubiquitin-related modifier 1), but the functional significance of this modification is not 
clear (Suzuki et al., 2001). 
 
B) Protein protein interactions 
Consistent with its proposed role in different metabolic process WRN has been 
identified to interact with several proteins. WRN helicase function at telomeres through 
its interaction with TRF2 and co-localization with the ALT pathway proteins TRF1, TRF2, 
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PML, RAD52, and NBS1 (Opresko et al., 2002) (Figure 2.7). Consistent with a role of the 
WRN helicase role in transcription, it was shown that WRN is associated with the RNA 
polymerase I complex (Balajee et al., 1999). The role of WRN in DNA replication is 
evident by the purification of WRN with a 17S multiprotein DNA replication complex 
containing PCNA, topoisomerase I and RPA (Lebel and Leder, 1998; Lebel et al., 1999). 
However, the functional significance of this interaction during the DNA replication 
process is not clear. Additionally, the C-terminus of WRN interacts with FEN1 and 
stimulates the endonucleolytic activity of FEN1 on a flap substrate (Brosh et al., 2001). 
Interestingly, p53 interacts with WRN and inhibits the unwinding of a synthetic Holliday 
junction by WRN (Blander et al., 1999). Finally, WRN also interacts with several proteins 
involved in the DNA non-homologus end-joing (NHEJ) double strand repair pathway and 
its enzymatic activity is regulated by phosphorylation events promoted by the DNA-PKcs 




                         
Figure 2.7 :  Potential role of WRN and few of its interaction partners in human cells. (A) Telosome 
complex and telomere structure. The telomere folds back onto itself to form a double-stranded t-loop and 
a single-stranded D-loop. This complex protects telomeres at the G2 phase of the cell cycle from 
inappropriate NHEJ- and HR-mediated processing of telomeric DNA. The six-component telosome is 
shown schematically on the t-loop, with POT1 interacting with the D-loop. (B) During DNA replication, the 
presence of WRN at the replication fork is postulated to enable the replication complex to efficiently 
replicate telomeric DNA. (C) The presence of WRN at telomeres may facilitate unwinding of the D-loop, 
enabling telomerase to extend telomeres. The linear 3' overhang is probably protected by POT1. Model 
adopted from (Multani and Chang 2007). 
 
 
2.2 RECQ5 helicase 
The RECQ5 gene has 19 exons and by alternate splicing, it gives rise to three isoforms, 
namely RECQ5α, RECQ5β, and RECQ5γ. These proteins are 46 kDa, 108.9 kDa, and 49 
kDa, respectively (Shimamoto et al., 2000). Among the three isoforms only RECQ5β has 
the nuclear localization signals. Sequence analysis revealed that RECQ5 gene is located 
onto chromosome 17q25 and mutations in this region leads to ovarian cancers and 
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breast carcinomas (Sekelsky et al., 1999). RECQ5 isoforms are ubiquitously expressed 
with relatively high expression in testis and their expression level does not change 
during any stages of the cell cycle (Ozsoy et al., 2001). There are no reports about 
genetic diseases associated with RECQ5 gene mutation published to date. 
 
2.3.1 Clinical manifestations of RECQ5 deficiency 
A) Murine model 
The Recq5 knockout mice generated by deleting exon4 showed a cancer susceptibility 
phenotype. Specifically, they developed lymphomas. However, Recq5 knockout mice 
had a normal life span suggesting RECQ5 is not essential for normal embryonic 
development in mice (Hu et al., 2009). 
B) Cellular phenotype 
Primary mouse embryonic fibroblasts (MEF) cells derived from Recq5 knockout mice 
showed an elevated rate of spontaneous double-strand breaks (DSBs), homologous 
recombination (HR), and showed significant increase in sister chromatid exchange 
frequency. Recq5-deficient cells also accumulate
 
Rad51 and -H2AX foci and are prone 
to gross chromosomal rearrangements
 
in response to replication stress. Moreover, 
RECQ5 defecient cells were sensitive to camptothecin treatment and cell survival assays 
showed proliferation defects upon CPT treatment (Hu et al., 2009). Wang and colleagues 
deleted
 
the chicken RECQL5 homologue in DT40 cells. They detected no
 
effect of RECQL5 
deletion on the frequency of spontaneous SCE.
 





increased the frequency of SCE (Wang et al., 2003). These 
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2.3.2 Structural aspects of the RECQ5 protein 
A) Domain architecture  
 
RECQ5β contains an N-terminal, RQC, HRDC, and C- terminal domain. The large C-
terminal region includes a domain homologous to the non-helicase domain of the E. coli 
RecQ DNA helicase, and it is responsible for the strand annealing activity of RECQ5β. 
This domain is also required for unwinding lagging strand duplex DNA and for DNA 
strand exchange (Aygun and Svejstrup). Interestingly, the N-terminal is small in contrast 
to the N-terminal of other RecQ helicases, and the function of this short N-terminal of 
RECQ5 is not known yet (Kawasaki et al., 2002). 
B) Assembly state 
Unlike other RecQ helicases, RECQ5 forms monomers both in its free and DNA/ATP 
bound forms suggesting that RECQ5 unwinds DNA as a monomer (Garcia et al., 2004). 
However, baculovirus expressed dmRecQ5β was suggested to form higher-order 
oligomeric structures dmRecQ5β by gel-filtration experiments. Interestingly, GTP 
binding triggers the helicase activity of dmRecQ5β (Kawasaki et al., 2002). 
 
2.3.3 Biochemical characteristics of the RECQ5 protein 
A) Enzymatic properties 
The in-vitro biochemical characterization of the purified recombinant human RECQ5 
protein shows DNA-dependent ATPase and ATP-dependent DNA helicase activities. The 
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DNA helicase activity of RECQ5 has 3′–5′ polarity, consistent with the general properties 
of the other RecQ helicases. Interestingly, unlike other RecQ helicases the unwinding 
activity is not stimulated by RPA and the annealing activity is inhibited by the addition of 
RPA (Garcia et al., 2004). Like other RecQ helicases, RECQ5 unwinds conventional model 
replication forks and Garcia et al. showed that RECQ5 has the ability to branch migrate 
Holliday junctions (Garcia et al., 2004). 
 
2.3.4 Functional role of the RECQ5 protein 
Available literature suggests that RECQ5 is a tumor suppresser protein. In particular, it 
minimizes the propensity of oncogenic rearrangements by suppressing the accumulation 
of DSBs and attenuating HR by disrupting inappropriate RAD51 presynaptic filaments  
(Hu et al., 2007). Conflicting data regarding the role of RECQ5 in transcription have been 
reported. RECQ5 association with RNAPII in vivo suggests the possible role of RECQ5 in 
transcription However, latter reports suggested that RECQ5 acts as an inhibitor of 
transcription (Aygun et al., 2008; Aygun et al., 2009). The exact mechanism of 
transcription regulation by RECQ5 is not yet clear Thus, RECQ5 has been proposed to 
promote genome stability through two parallel mechanisms: by participation in 
homologous recombination-dependent DNA repair and by regulating initiation of Pol II 
to reduce transcription-associated replication impairment and recombination. 
RECQ5 may play an additional role in stabilization and/or restart of stalled replication 
forks. This was suggested by the findings that mouse Recq5-/- embryonic stem (ES) cells 
and primary embryonic fibroblasts are hypersensitive to camptothecin (CPT), a 
topoisomerase I inhibitor that blocks DNA replication (Hu et al., 2009). 
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2.3.5 Regulation of the RECQ5 protein function 
A) Protein protein interactions 
In line with its proposed functions in transcription and homologus recombination, 
RECQ5 has been shown to interact with various proteins involved in these pathways. In 
particular, RECQ5 is the only member of RecQ helicase which directly interacts with RNA 
polymerase II (RNAPII). This interaction is mediated by the RPB1 subunit of RNAPII 
(Aygun, Svejstrup et al., 2008) (Figure 2.8). Recent finding’s from Weidong Wang’s lab, 
using chicken DT40 cells inactivated for RECQL5, demonstrated that Pol II is a critical 
partner of RECQL5 in suppression of SCE and resistance of CPT-induced cell death. 
Moreover, they identified two conserved domains in RECQL5, KIX and SRI, and showed 
that they are responsible for interacting with Pol II (Islam et al.).  
         RECQL5β interacts and co-localizes with FEN1 in
 
the nucleus in response to DNA 
damage and this interaction stimulates the flap endonucleases activity of FEN1 
suggesting that the interaction with FEN1 is essential for the DNA repair function of 
RECQ5 helicase (Speina et al.). In addition, Pavel Janscak’s group has purified FLAG-
RECQ5 in complex with PCNA, Topoisomerase III /β, and the MCM complex proteins, 




Figure 2.8: Potential role of RECQ5 and its interaction partner RNAP II in human cells. Potential 
mechanisms by which RECQ5 may affect RNAPII transcription (A). RECQ5 may inhibit at least 2 critical 
events in the early initiation stages of RNAPII transcription. First, RECQ5 may directly compete with one of 
the initiation factors and de-stabilize pre initiation complexes. RECQ5 may also exert an allosteric 
inhibitory effect on the catalysis of first phosphodiester bond formation by RNAPII (B). During elongation 
RECQ5 may form a stable complex with RNAPII ternary elongation complex and this binding may result in 
a conformational change in the holoenzyme. Consequently the processivity of the enzyme may be 
reduced. Finally, RECQ5 may destabilize the associated RNAPII elongation complex or stimulate its 
transient pausing, which may be relieved by a positive elongation factor such as TFIIS. However, the fact 
that RECQ5 is capable of inhibiting RNAPII transcription in the absence of other co-factors indicates that 






2.4 RECQ4 helicase 
The RECQ4 helicase is a structure specific DNA helicase of 1208 amino acid residues. The 
Recq4 gene has been identified on chromosome 8q24.3 (Kitao et al., 1998). Mutations in 
this gene leads to three different genetic disorders namely Rothmund –Thomson (RTS), 
RAPADILINO, and Baller-Gerold (BGS) syndromes (Islam et al., ; Kitao et al., 1999; Lindor 
et al., 2000; Lype et al., 2008; Siitonen et al., 2003). RECQ4 is expressed in testis, 
prostate and thymus. At cellular level, RECQ4 is found both in nucleus and cytoplasm 
and the expression of RECQ4 is regulated throughout the cell cycle with a peak of 
expression during the S phase (Sengupta et al., 2005). 
 
2.4.1 Clinical manifestations of RECQ4 deficiency 
A) Human syndromes associated with RECQ4 deficiency 
Rothmund –Thomson syndrome (RTS): Mutations in helicase domain of Recq4 gene 
leads to RTS. The patients show poikiloderma, growth deficiency, juvenile cataracts, 
premature aging and a predisposition to malignant tumours, particularly osteosarcomas 
(Figure 2.9) (Balraj et al., 2002; Kitao et al., 1999; Lindor et al., 2000). 
RAPADILINO: Mutations which leads to in-frame deletion of exon 7 of Recq4 gene are 
the cause of RAPADILINO syndrome, where the patients show RAdial hypo-/aplasia, 
PAtellae hypo-/aplasia and cleft or highly arched palate, DIarrhoea and DIslocated 
joints, LIttle size and LImb malformation and Nose slender (Siitonen et al., 2003). 
Baller-Gerold syndromes (BGS) : Mutations in the exon 9 of Recq4 gene leads to BGS. 
The clinical features of the patients are radial aplasia/hypoplasia and craniosynostosis  




                                                             
                                  Figure 2.9 : A RTS patient showing bone abnormalities  
 
 
 B) Murine model 
Three RECQ4 knockout mice have been reported so far. The first mice with a knockout 
of exon 5-8, covering the N-terminal, proved to be embryonic lethal (Ichikawa et al., 
2002) suggesting a very important function of this N-terminal domain.  The second 
mouse where part of exon 13 which codes for part of the helicase domain was knocked 
out, showed severe growth retardation and other organismal phenotypic characteristics 
resembling RTS patients (Hoki et al., 2003). The third mouse where exon 9 to 13 were 
knocked out showed typical RTS clinical features such as hypo-/hyperpigmented skin, 
skeletal limb defects and palatal patterning defects (Mann et al., 2005). The existence of 
two mouse models with similar phenotype of RTS patients confirms that mutation in the 





C) Cellular phenotype 
The cells derived from RTS patients show genomic instability, including trisomy, 
aneuploidy and chromosomal rearrangements. Likewise, cytogenetic analysis of the 
embryonic fibroblasts (MEF) derived from Recq4 knockout mice revealed overall 
aneuploid phenotype and a significant increase in the frequency of premature 
centromere separation (Hoki et al., 2003). Such wide range of disruptions of the 
chromosome could likely be the reason for the carcinoma’s, RTS, BGS, and RAPADILINO.  
Additionally, RTS cells are sensitive to ionizing radiation and oxidative stress/damage 
suggesting a possible role in DNA break repair. Acute depletion of RECQ4 protein in 
primary murine embryo fibroblasts leads to defects in DNA synthesis and cell 
proliferation (Sangrithi et al., 2005) which is consistent with embryonic lethality of  
RECQ4 knockout mice. 
 
2.4.2 Structural aspects of RECQ4 protein  
A) Domain architecture 
Although RECQ4 has the seven domain that characterize the helicase domain of all the 
RecQ helicases, it lacks the RQC and HRDC domain that characterize most of the 
members of the RecQ family. A number of acidic amino acid residues are found at the C-
terminal region of RECQ4, while this acidic amino acid residues are generally found at 
the N-terminus of other RecQ helicases (Xu and Liu, 2009). The N terminal domain of 
Xenopus RECQ4 shows sequence similarity to yeast Sld2/DRC1 complex which is 
responsible for the establishment of replication forks (Matsuno et al., 2006; Sangrithi et 
al., 2005) However, this similarity only limited to the first 70 amino acids in the case of 
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human RECQ4 and, surprisingly the N-terminal of human RECQ4 was found to have an 
intrinsic DNA helicase activity (Xu and Liu, 2009). Several mutations in the helicase 
domain have been identified in RTS patients (Figure 2.10).  
 
 
Figure 2.10 :Schematic depiction of wild type RECQ4 with characterized mutations leading to RTS.  
The positions of the mutations found in the RTS patients with FS referring frameshift type of mutation 
(Kitao et al., 1999; Lindor et al., 1999). 
 
 
2.4.3 Biochemical characteristics of RECQ4 helicase 
A) Enzymatic properties  
Recombinant RECQ4 purified from E.Coli showed ATP dependent DNA unwinding 
activity with a 3’ to 5’ polarity (Macris et al., 2006). Interestingly, a recent study 
suggested that the unwinding activity is derived both from the helicase domain and the 
Sld2 domain (Xu and Liu 2009). Moreover, RECQ4 has strand annealing activity as 
demonstrated using the E.coli purified recombinant protein and the immuno-purifyed 
endogenous protein (Macris et al., 2006; Xu and Liu, 2009; Yin et al., 2004). 
Apart from usual replication fork like structures, RECQ4 can unwind 61 bp blunt-end 
duplex DNA containing either a 12-nt bubble, a 4-nt bubble, or even without a bubble 




2.4.4 Functional role of the RECQ4 protein 
RECQ4 is implicated in different DNA metabolic processes, as suggested by three 
different genetic diseases associated with Recq4 mutation. First, RECQ4 has been 
proposed to function in initiation of DNA replication. Consistently, the N-terminal of 
xRECQ4 shows sequence similarity to yeast Sld2 which has been shown to participate in 
DNA replication initiation. Its role in DNA replication is further supported by lethal 
phenotype of knockout mice, the cellular phenotype showing defect in DNA synthesis, 
and recent immunoprecipitation experiments showing that human RECQ4 is in 
association with replication complex proteins (Matsuno et al., 2006; Sangrithi et al., 
2005; Xu et al., 2009a). Moreover, a recent study demonstrated that RECQ4 is essential 
for the assembly of CDC45-MCM-GINS (CMG) complex, thus initiating the DNA 
replication (Im et al., 2009). 
Second, RECQ4 has been shown to participate in various DNA repair pathways. Petkovic 
et al reported that after etoposide treatment RECQ4 nuclear foci coincide with the foci 
formed by Rad51, a crucial protein functioning in homologous recombination (Petkovic 
et al., 2005). In addition, fibroblasts from RTS patients (RTS cells) are sensitive to ionizing 
radiation (Jin et al., 2008) and Kumata et al recently provided the evidence that RECQ4 
participates in DSB repair in Xenopus egg extracts (Kumata et al., 2007). RECQ4’s role in 
DSB repair pathway was further supported by a recent report from Wilhelm Bohr’s 
group where they showed that RECQ4 participates in Nucleotide Excision Repair (NER). 
The authors of this study demonstrated that the complementation with functional 
RECQ4 could remove the UV lesions and rescued the UV sensitivity of RTS cells (Park et 
al., 2006). Third, Woo and Werner reported that RECQ4 plays a role in oxidative stress. 
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They observed that, upon oxidative stress, RECQ4 shifts to nuclear foci and interacts 
with PARP1 (Woo et al., 2006). Fourth, RECQ4 has also been reported to control S phase 
arrest. Cells defective in RECQ4 escaped from the S-phase arrest following UV treatment 
(Park et al., 2006). These data altogether suggest that RECQ4 is involved in DNA 
replication, distinct DNA repair processes, and possibly cell cycle arrest. 
 
2.4.5 Regulation of the RECQ4 protein function 
A) Post translational modifications 
RECQ4 is acetylated both in-vitro and in-vivo by p300 and the acetylated lysine residues 
are found in the nuclear localization signal region. Acetylation of RECQ4 regulates the 
nuclear trafficking as the acetylated form of RECQ4 stays in the cytoplasm (Dietschy et 
al., 2009) suggesting that acetylation might also regulate the DNA repair function of 
RECQ4. RECQ4 is a phosphoprotein, CDK phosphorylates Sld2-like domain of RECQ4 and 
this phosphorylation modulates the interaction of RECQ4 with MCM10, thus suggesting 
that phosphorylation might also regulate the replication role of RECQ4 
(Xu et al., 2009a). RECQ4 was also shown to be poly(ADP-ribosyl)ated in vitro (Woo et 
al., 2006).  When cells are treated with oxidative stress, RECQ4 interacts with PARP1 and 
gets poly(ADP-ribosyl)ated suggesting that this modification might also regulate the 
RECQ4 activity in DNA repair. 
 
B) Protein - protein interactions 
Two independent studies support a role of RECQ4 in DNA replication by showing that 
RECQ4 co-purifyies  with the replication initiation complex proteins. Xu et al isolated the 
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complex containing MCM and GINS complex proteins through immuno-purification of 
FLAG tagged RECQ4. They also demonstrated that the association of RECQ4 with 
initiation complex is mediated through MCM10 (Xu, Rochette et al. et al., 2009a). Jun-
Sub Im et al. used a bimolecular florescence complementation assays to demonstrate 
the existence of the same complex in HeLa cells. Furthermore, they observed that the 
stable association of CMG (CDC45,GINS,MCM) complex requires RECQ4 (Im et al., 2009) 
(Figure 2.10). 
RECQ4 also interacts with PARP1 and PARP cn poly(ADP-ribosylate) RECQ4 suggesting 
that the interaction with PARP1 is essential to withstand the oxidative stress (Woo,  
Futami et al., 2006) 
Furthermore, RECQ4 interacts with RAD51 invivo and co-localizes with RAD51 when the 
cells are treated with the DNA damaging agent etoposide, supporting a role of RECQ4 in 
DNA replication (Petkovic et al., 2005). RECQ4 interacts with UBR1 and UBR2, however 
RECQ4 is not ubiquitylated (Yin et al., 2004) and the functional significance of this 
interaction is not known yet. 
 
                    
 
Figure 2.11: Potential role of RECQ4 and its interacting partners. RECQ4 interaction with the MCM 




2.5 RECQ1 helicase 
RECQ1 helicase is the first RECQ helicase identified to be a human homologue of the 
E.coli RecQ helicase (Puranam and Blackshear, 1994). The cDNA cloning and FISH 
analysis localized the RECQ1 gene on the short arm of human chromosome 12 at 12p12  
(Puranam and Blackshear, 1994). It encodes a 649 amino acid polypeptide with a 
predicted molecular weight of 73 kDa. The protein shares a high sequence similarity 
with E.coli RecQ and other human RecQ helicases. The expression of RECQ1 is 
significantly high in testes and ovaries (Olesen, 2007; Wang, 2003 ). At the cellular level, 
RECQ1 is found both in the cytoplasm and the nucleus, and it is ubiquitously expressed 
throughout the cell cycle. Though there is no human syndrome associated with RECQ1 
deficiency, mutations in the RECQ1 gene are associated with testicular germ cell 
tumours (Suijkerbuijk et al., 1993). 
 
2.5.1 Clinical manifestations of RECQ1 deficiency 
A) Knockout mice 
RECQ1 knockout mice was produced by replacing helicase domain IV and part of 
helicase domain V with PGKNeo of the targeting vector, Pjn52/RECQL. The resulting 
RECQ1 deficient mice did not show any apparent phenotypic differences  compared with 
the wild type mice (Sharma et al., 2007). 
B) Cellular phenotype 
Cytogenetic analysis of the embryonic fibroblasts (MEF) derived from RECQ1 knockout 
mice revealed aneuploidy, suggesting a role of RECQ1 during segregation of 
chromosomes during mitosis. M-FISH analysis revealed increase in fragmented 
42 
 
chromosomes, chromatid breaks, translocation events, and sister chromatid exchanges. 
These cells accumulate DNA damages, evident by the increase in γH2AX and RAD51 foci 
formation. In addition, RECQ1 deficient cells are hypersensitive to ionizing radiation. 
Interestingly, acute depletion of RECQ1 in HeLa cells resulted in reduced cell 
proliferation. Colony forming assays performed by Sharma et al., showed a significant 
reduction in both the size and number of colonies, when HeLa cells were inhibited for 
the expression of RECQ1. Along with the cell proliferative role, a cancer-specific role of 
RECQ1 was suggested based on two observations. First, RECQ1 silencing in cancer cells 
resulted in mitotic catastrophe and second, the expression of RECQ1 is upregulated in 
actively proliferating cells and also upon cellular transformation by EBV or SV40 T 
antigen (Sharma, Stumpo et al. 2007) . 
 
2.5.2 Structural aspects of the RECQ1 protein 
 
 A) Domain architecture  
 
The domain organization of RECQ1 closely resembles that of the bacterial RecQ with 
high similarity in helicase domain and in RecQ family specific zinc domain. However, the 
C-terminal domain which folds as Winged Helix (WH) domain is characterized by a β-
hairpin loop that is longer than in the bacterial counterpart. The C-terminal domain also 
possesses nuclear localization signal (NLS), while the N terminal domain has been shown 
to be involved in the formation of higher order oligomers (Pike et al., 2009).    
The truncated RECQ1, consisting of residues 49-616 (of 649) was crystallized with 
ADPand Mg
2+ 
 (Figure 2.11). Crystal structure of RECQ1 is similar to that of E.coli RecQ. 
However, the Winged Helix (WH) domain is positioned differently and the β-hairpin loop 
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of the WH domain is longer when compared to E.coli RecQ. The biochemical 
characterization of a truncated form of RECQ1 revealed that this β-hairpin loop plays an 
important role in DNA strand separation (Pike et al., 2009).  
 
 
Figure  2.12: Crystal structure of human RECQ1. Ribbon representation of a single RECQ1 molecule, 
viewed from 3 perpendicular orientations. The subdomains are identified by color: Core helicase domain 
D1, red;core helicase domain D2, blue; zinc motif (ZnD), yellow;helical hairpin (HH), orange; WH domain, 
green; and the β-hairpin in purple. ADP is shown in spacefilling form (Pike et al., 2009). 
 
 
C) Assembly state 
ATP binding and ssDNA modulate two different quaternary states of RECQ1. These two 
different states are associated the unwinding and annealing activity of RECQ1 (Figure 
2.12). RECQ1 forms higher-order oligomeric structures and these oligomers promote the 
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strand annealing acivity. On the other hand, ATP binding promotes the formation of 
smaller oligomers (dimers or monomers)  and favours the unwinding reaction (Muzzolini 




Figure 2.13 :  Schematic representation of different quaternary structures of human RECQ1.Higher order 
oligomers promote strand annealing and smaller oligomers catalyze DNA unwinding. 
 
2.5.3 Biochemical characteristics of the RECQ1 helicase 
A) Enzymatic properties 
The RECQ1 helicase is an ATP- and Mg
2+
-dependent enzyme that unwinds DNA with a 3’ 
to 5’ polarity. RECQ1 also possesses a DNA strand annealing activity and the assembly 
state of RECQ1 regulates the unwinding and annealing activity (Muzzolini et al., 2007). 
RECQ1 can unwind a variety of DNA substrates including the conventional B-form 
duplexes. The higher order oligomers of RECQ1 are required to resolve synthetic HJ 
structures in an ATP dependent way. RECQ1 also unwinds D-loops which are the 
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intermediates of homologous recombination. The unwinding function of RECQ1 is 
distinct from that of BLM since RECQ1 cannot unwind G-quadruplexes, DNA-RNA 
hybrids and  cannot catalyze fork regression or displace plasmid D loops lacking a 3’ tail. 
However, RECQ1 is able to unwind HJ lacking an homologous core, unlike the BLM 
(Popuri et al., 2008).  
 
2.5.4 Functional role of the RECQ1 protein 
 The increased load of DNA damage and the elevated sister chromatid exchanges in the 
RECQ1 defecient cells suggest that RECQ1 is involved in suppressing chromosomal 
instability (Sharma, Stumpo et al. 2007). A role of RECQ1 in DNA repair has been 
suggested by the ionic radiation sensitivity of RECQ1 defecient cells and by the 
interaction of endogenous RECQ1 with some DNA mismatch repair proteins (Doherty et 
al., 2005). However, the exact function of RECQ1 in the maintenance of genome stability 
is still unknown. 
 
2.5.5 Regulation of the RECQ1 protein function 
A) Post translational modifications 
RECQ1 appears to be phosphorylated when the cells are exposed to ionic radiations (IR). 
This phosphorylation event was suggested to help RECQ1 in associating with chromatin 
when the cells are exposed to IR (Sharma and Brosh, 2007). However, the 





B) Protein - protein interactions 
Several DNA repair proteins such as MSH2/6, MLHI-PMS2, EXO1 and RAD51 have been 
shown to associate with RECQ1 helicase by co-immunoprecipitation experiments. The 
functional role of these interactions is still unknown (Doherty et al., 2005; Sharma and 
Brosh, 2007). RPA also interacts with RECQ1 and this interaction is mediated by the 
RPA70 subunit. Co-immunoprecipitation experiments using human nuclear extracts 
confirmed that RECQ1 and RPA interact in cells. Importantly, RPA stimulates the ability 
of RECQ1 to unwind duplex DNA substrates. RPA stimulation of RECQ1 helicase activity 
increases the processivity of RECQ1. RECQ1 alone in unableto unwind DNA duplexes 
exceeding 100 bp, while it can unwind much longer duplexes of 500 bp in the presence 






3. DNA replication 
DNA replication is a highly coordinated process which ensures efficient inheritance of 
the genetic information and accurate doubling of the cell. In eukaryotic cells, this event 
is initiated at particular sequences called origins of replication and this region is marked 
by the binding of the origin recognition complex (ORC). ORC acts as a landing pad and 
the pre-replicative complex proteins namely ORC, Cdc6p, Cdt1p, and MCM assemble as 
a multiprotein complex on ORC-defined sequences (Aparicio et al., 1997; Diffley et al., 
1994; Tanaka et al., 1997). This loading is permitted by the low activity of cyclin 
dependent kinases (CDK) during the G1 phase of the cell cycle. An increase in CDK 
activity at the G1/S transition allows the binding of CDC45 to the MCM complex, 
followed by the binding of GINS proteins . Thus, pre-RC complex is converted into the 
initiation complex and starts unwinding. The high CDK activity during S and G2 phases 
prevents the re-formation of pre-RC until the end of mitosis (Aparicio et al., 1997; 
Nasmyth, 1996; Zou and Stillman, 1998). The unwound origins are stabilized in the single 
stranded state by the binding of RPA and the subsequent binding of DNA polymerase α 
and ε leads to the synthesis of daughter strand (Aparicio et al., 1997). The entire DNA 
replication process is tightly regulated along cell cycle to ensure the formation pre-RC 
during G1 phase and initiation complex just before the S phase. This process  is 
monitored by check point mechanisms. In case of any block in DNA replication or DNA 
damage, a signal transduction pathway is activated resulting in a block of further 
initiation events in S phase and promoting the entry in mitosis (Nyberg et al., 










. Figure 2.14 : Model for eukaryotic DNA replication.The origin recognition complex is assembled at 
origins in the early stages of G1. Cdc6 and Cdt1 are required for the association of the Mcm2-7 protein 
family, resulting in the formation of the prereplicative complex (pre-RC). After activation of the DBF4-
dependent kinase (DDK) and cyclin-dependent kinase (CDK) complexes, the transition from the pre-RC to 
the preinitiation complex (pre-IC) occurs at G1/S and is characterized by the formation of the CMG 

















3.1 Human DNA Replication origins 
Mammalian cells regulate the rate of DNA replication by activating or deactivating the 
starting points of DNA replication called “Origins of DNA replication”. This regulation is 
achieved through the cellular phase-specific assembly and reorganization of multi 
protein complexes on the DNA sequences marked as origins by the ORC. Nascent DNA 
analysis and 2-D gel electrophoresis helped initially to identify the replication origins. 
However, recent studies using origin trapping assay, high throughput assays combining 
nascent strand abundance analysis with microarray data and genome wide high 
resolution maps based on hybridization of short nascent strands (SNS) on DNA 
microarrays covering The Encyclopedia of DNA Elements (ENCODE), helped to identify 
almost 283 replication origins in 1% of the human genome (Cadoret et al., 2008; Giacca 
et al., 1997; Giacca et al., 1994; Lucas et al., 2007; Todorovic et al., 2005).  
                There are several features that decide the particular locus of the DNA to 
function as origins. Unlike S. cerevisiae, there are no consensus sequences in humans 
that function as origins; however chromatin conformations, chromatin 
hyperacetylations which recruits ORC complex, presence of CpG islands, presence of 
chromosomal scaffold attachment sites, presence of transcriptional regulatory elements 
(ORC is localized to specific sequences that overlap with RNA pol II binding sequences) 
probably decide the location of DNA replication origins  (Falaschi et al., 2007; Paixao et 
al., 2004). The firing of replication origins are tightly connected with “ S” phase of the 
cell cycle. Even though several origins have characteristic early S phase firing while 
others have  mid/late S phase firing, the firing occurs only in the S phase of the cell cycle 
(Gilbert 2001).  
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3.2 Human Lamin B2 replication origin 
Although 283 replication origins are identified so far, very few origins have been 
characterized in detail. The human lamin B2 replication origin, which is located 
downstream of the human lamin B2 gene is one of the best characterized so far. 
Competitive PCR analysis of the nascent DNA library from HL-60 cells was used  to 
localize a genomic segment with “origin activity” in the G-negative p13.3 band of 
chromosome 19, at the 3’ portion of the ORF for lamin B2 and upstream of the 
promoter of TIMM13 (Biamonti et al., 1992). This origin fires immediately at the onset 
of S phase and its activity has been reported in various cell lines including myeloid, 
epithelial, neuronal, fibroblasts, and primary peripheral lymphocytes (Kumar et al., 
1996). The in vivo foot printing experiments revealed a footprint around replication 
initiation sites and these protein DNA interactions at the origins underwent changes 
during the cell cycle. There was no footprint observed in G0 phase cells but there was a 
footprint covering 100bp during G1/S and this footprint shrinks to 70 bp during S phase 
and completely disappears during mitosis. Of note, there were no such footprints in non 
proliferating cells. The footprinting experiments combined with ligation mediated PCR 
analysis showed that a 1.2-kb fragment of the lamin B2 replicon functions as a replicator 
even if it is integrated at ectopic positions of the genome.YThis study precisely showed 
that a 290 bp region containing the OPR (Origin protected Region) decides the replicator 
activity and is influenced by the nearby CpG island (Paixao, Colaluca et al., 2004). 
Successively, two precise nucleotides of the lamin B2 origin from which bidirectional 
DNA synthesis starts have been identified (Abdurashidova et al., 2000). Several proteins 
have been shown to interact with the lamin B2 replication origin. In particular, the 
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interaction of the pre-replication complex proteins and initiation complex proteins with 
the lamin B2 origin have been reported (Abdurashidova et al., 1998; Dimitrova et al., 
1996; Stefanovic et al., 2003).  
 
3.3 Replication fork stability 
 
At each fired origin, two sister replication forks (RFs) are established that move away 
from the origin as the parental DNA duplex is unwound by the action of DNA helicases. 
The RFs can be hindered by structural and chemical alterations in the DNA. When one 
RF is terminally blocked or arrested, firing of dormant or nearby origins ensures that 
replication is complete (Doksani et al., 2009). Checkpoints are cellular surveillance and 
signalling pathways that detect DNA lesions, such as ssDNA or DSBs, and then boost a 
DNA damage response that ensures replication fork (RF) stabilization (Branzei and 
Foiani, 2007). Ataxia telangiectasia mutated (ATM) dependent pathway and ATM- and 
Rad3-related protein (ATR) dependent pathway are key checkpoint mechanisms that 
safeguards the replication fork. ATM responds mostly to DSBs (Costanzo et al., 2000) 
and is recruited to the damaged replication fork through the MRN complex (Uziel et al., 
2003) which is composed of MRE11, RAD50, and NBS1. The MRN complex proteins 
activate ATM (Lee and Paull, 2004) leading to phosphorylation of the downstream 
cellular targets p53 and Chk2 that inhibita the further firing of origin by degrading 
CDC25 (Costanzo et al., 2004; Falck et al., 2005; Jazayeri et al., 2008; Lee and Paull, 
2005; Uziel et al., 2003). On the other hand, ATRresponds mostly to single-strand DNA 
gaps coated with RPA at stalled RFs (Costanzo et al., 2003). Similar to ATM activation, 
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ATR phosphorylates downstream proteins and induces the degradation of CDC25 
thereby inhibiting firing of the origins.        
 
  
Figure 2.15 : Maintenance of active replication forks by checkpoint system. ATM or ATR pathway is 
activated to slowdown the progression of damaged replication forks and to activate the dormant or 




4. RECQ helicases in DNA replication 
DNA replication is one of the key processes where any defect could potentially lead to 
genome instability. Several lines of evidence suggest that RecQ helicases play an 
important role in DNA replication control (Bachrati and Hickson, 2008; Chu and Hickson, 
2009). In particular, RecQ helicases are thought to facilitate replication by  preserving 
the integrity of stalled replication forks and by remodeling or repairing damaged or 
collapsed forks to allow the resumption of replication. Consistent with these ideas, 
several investigators have shown that primary fibroblasts from BS, WS and RTS patients, 
and RecQ5- deficient mouse embryonic fibroblasts show differential hypersensitivity to 
agents that perturb DNA replication (Davalos et al., 2004; Dhillon et al., 2007; Hu et al., 
2009; Jin et al., 2008). Moreover, BLM and WRN are recruited to DNA replication forks 
after replicative stress, and DNA fiber track analyses have shown that both BLM and 
WRN are required for normal fork progression after DNA damage or replication arrest 
(Constantinou et al., 2000; Davies et al., 2007; Sakamoto et al., 2001; Sidorova et al., 
2008). Biochemical and functional data indicate that RecQ helicases may act directly on 
the replisome or replication fork. For example, several RecQ helicases have been shown 
to interact physically or functionally with core replication components such as 
proliferating cellular nuclear antigen (PCNA), replicative and translesion synthesis DNA 
polymerases, human replication protein A (RPA) and DNA topoisomerases (Brosh et al., 
2000; Cui et al., 2004; Kamath-Loeb et al., 2000; Lebel et al., 1999; Rodriguez-Lopez et 
al., 2003; Selak et al., 2008). The conserved interaction of WRN and BLM with FEN1 
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nuclease suggests a role of these two helicases in Okazaki fragment maturation during 
lagging strand replication (Sharma et al., 2004a; Sharma et al., 2004b). 
         RecQ helicases may also act on replication intermediates to facilitate the 
completion of replication. For example, BLM, WRN, and RECQ5 have all been shown to 
promote the regression or remodeling of model stalled forks in vitro, a reaction that 
could facilitate replication restart (Kanagaraj et al., 2006; Machwe et al., 2006; Ralf et 
al., 2006). In particular, BLM in conjunction with DNA toposiomerase III and other two 
accessory proteins, RMI-1 and RMI-2, has been shown to catalyze the resolution of 
double Holliday junction recombination intermediates to generate non-crossover 
products. This ‘dissolution’ reaction could play an important role in the error-free 
recombinational repair of damaged or stalled forks during S-phase (Singh et al., 2008; Xu 
et al., 2008). WRN also appears to promote error-free repair by contributing to the 
resolution of gene conversion events to generate non-crossover products (Saintigny, 
Makienko et al., 2002). In line with the above observations, WRN and BLM can be found 
associated with replication foci or other DNA damage response proteins in damaged 
cells. In contrast, in unperturbed cells, a majority of each protein is found in the 
nucleolus (WRN) or associated with PML bodies (BLM) (Bischof et al., 2001; Marciniak et 
al., 1998). RECQ4 has also been implicated in DNA replication. Recent studies have 
shown that hypomorphic mutants of the D. melanogaster homolog of human RECQ4, 
DmRECQ4, have reduced DNA replication-dependent chorion gene amplification (Wu, 
Capp et al., 2008). These findings are thus consistent with a postulated role for X. laevis 
RECQ4 (XRECQ4) in the initiation of DNA replication (Matsuno et al., 2006; Sangrithi et 
al., 2005). The N-terminus of XRECQ4 bears homology to the N-termini of the yeast 
56 
 
proteins Sld2 (S. cerevisiae) and DRC1 (S. pombe), which in association with budding 
yeast Dpb11 and the fission yeast homolog Cut5/Rad4 play a central role in the 
establishment of DNA replication forks (Masumoto et al., 2002; Noguchi et al., 2002; 
Wang and Elledge, 1999). Consistently, the N-terminus of XRECQ4 has been shown to 
interact with the X. laevis variant of Cut5, and XRECQ4 depletion severely perturbs DNA 
replication initiation in X. laevis egg extracts (Matsuno et al., 2006; Sangrithi et al., 
2005). The notion that the function of XRECQ4 is evolutionarily conserved in mammals is 
supported by the observations that the human protein can complement its Xenopus 
counterpart in cell free assays for replication initiation, and that depletion of human 
RECQ4 inhibits cellular proliferation and DNA synthesis (Matsuno et al., 2006; Sangrithi 
et al., 2005). Moreover, deletion of the N-terminal region of mouse RECQ4 has been 
shown to be embryonic lethal (Ichikawa, Noda et al.et al., 2002). These observations 
suggest that vertebrate RECQ4 might be a functional homolog of Sld2, although its 
precise function during replication initiation and progression is not known. Recent 
reports, indicate that human RECQ4 interacts with the MCM replicative complex during 
replication initiation, and that this interaction is regulated by CDK phosphorylation of 
RECQ4 (Xu, Rochette et al., 2009a).  
RECQ1, the most abundant of the human RecQ helicases, has been demonstrated as an 
integral component of pre-replication complex required for the Kaposi sarcoma-
associated herpes virus replication. However, the role of RECQ1 in human DNA 





Figure 2.16 : Possible Role of RecQ helicases in DNA replication. RecQ helicases have been proposed to 
function in several steps of DNA replication such as fork establishment, fork regression, proof reading, 




Aim of the thesis 
Although RecQ helicases have shown to be involved in DNA replication, the exact roles 
of the five human RecQ enzymes in this process is still unclear. In order to better 
delineate the roles of human RecQ helicases in DNA replication, I investigated the in vivo 
interactions of all five human RecQ enzymes with three well-characterized human DNA 
replication origins by quantitative chromatin immunoprecipitation (ChIP) assays. I also 
determined how cell proliferation, DNA synthesis, nascent-origindependent DNA 
synthesis, chromatin binding of replication proteins, origin firing frequency, and 




3A. MATERIALS AND METHODS 
3.1. Antibodies. 
Polyclonal antibodies against RECQ1 (BL2074) and WRN (NB 100-471) were purchased 
from Bethyl Laboratories and Novus Biologicals, respectively. Polyclonal antibody raised 
against residues 60-111 of human RECQ4 was produced in Weidong Wang’s laboratory 
as described (Yin et al., 2004). Polyclonal antibodies against BLM and RECQ5 were, 
respectively, generous gifts from Ian Hickson (Wu et al., 2001) and Pavel Janscak 
(Kanagaraj et al., 2006). Anti-Orc2 (3B7) antibodies were from MBL. Polyclonal 
antibodies anti-ORC1 were produced and purified by immunization of rabbits with a His-
tagged Orc1 250-480 aa polypeptide (Todorovic et al., 2005). Cdc6 (N-19), MCM3 (N-19), 
MCM4 (H-300), Cyclin E (M-20), Cyclin A1 (H-432), PCNA (F-2), antibodies were from 
Santa Cruz Biotechnologies. RPA (BL915) antibody was purchased from Bethyl 
Laboratories. Anti-α-Tubulin (B-5-1-2) antibody was from Sigma. Anti-p84 (3F10) and rat 
anti-CldU/BrdU (BU1/75(ICR1)) antibodies were from Abcam. Mouse anti-IdU/BrdU 
(#347580) and anti-BrdU-FITC (#347583) antibodies were from BD Biosciences. Anti-rat 
Alexa 594-conjugated (A11007) and anti-mouse Alexa 488-conjugated (A11001) were 
from Molecular Probes.  
3.2. Oligonuceoltides. 
All oligonucleotides were chemically synthesized and purified by reverse-phase high 
pressure liquid chromatography (RP-HPLC) (Sigma-Aldrich, Suffolk, UK), and were 
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resuspended in Tris buffer (10 mM Tris-HCl, pH 7.5 ). Oligonucleotide sequences are 
reported in Table 3A.1. 
 
Table 3.1. Oligonucleotides used for real time PCR and competitive PCR analysis of the Lamin B2, 
GMCSF and beta-globin origins. 
 
3.3. Cell culture, synchronization and cell-cycle analysis.  
T98G/HeLa and IMR-90 cell lines were maintained in DMEM and MEM media, 
respectively, supplemented with Glutamax (Life Tecnologies) and 10% (v/v) FBS (Life 
Technologies). HEK293 cells containing stably expressing strep-hemagglutinin double-
tagged (SH) RecQ helicases were grown in DMEM media with 100μg/ml of hygromycin 
and 15μg/ml of blasticidine. K562 cell lines were instead maintained in RPMI media 
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supplemented with Glutamax and 10% (v/v) FBS. T98G cells were synchronized by 
serum starvation as previously reported
 
(Paolinelli et al., 2009; Takahashi et al., 2000) or 
by drug arrest with 0.8 mM mimosine (Sigma).  HeLa and K562 cells were synchronized 
with 0.8 mM mimosine. Synchronized cells were then analyzed for their cell cycle profile 
(DNA content) by propidium iodide staining (Sigma) and flow cytometry on a FACS 
Calibur (Becton Dickinson). Cell cycle profile distributions were determined with the 
Modfit LT 3.0 software. BrdU incorporation experiments were performed on transiently 
siRNA transfected cells 72 h post-transfection. Cells were pulsed for 1 h with BrdU 
(Sigma, final concentration 10 µM), and BrdU-positive cells were detected by using a 
mouse anti-BrdU-FITC primary antibody followed by an anti-mouse Alexa 488-
conjugated secondary antibody. Cells were collected and analyzed by flow cytometry on 
a FACSCalibur (Becton Dickinson) to simultaneously determine the cell-cycle profile 
(DNA content) by incorporation of propidium iodide and the S-phase cell population by 
incorporation of BrdU. Cell-cycle profile distributions were determined with the 
CellQuestPro and Modfit LT 3.0 software. DNA replication perturbation was achieved 
with 2 m M hydroxy urea for 20 hours. 
3.4. Chromatin immunoprecipitation assays. 
 Cells were fixed by adding formaldehyde (Fluka) directly to the cell culture medium at 
1% final concentration. Cross-linking was allowed to proceed for 7 min at 37
°
C and was 
stopped by the addition of glycine (Sigma) at a final concentration of 125 mM. Cells 
were washed and digested with 125 U micrococcal nuclease S7 (Roche) for about 1-2 x 
10
7
 cells, at 37
°
C for 15 min. Reactions were stopped by adding EDTA (20 mM final). 
Cells were washed and resuspended in HNNG buffer (20 mM HEPES pH7.5, 250 mM 
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NaCl, 0.5% NP40, 10% glycerol, 1 mM PMSF) supplemented with protease inhibitors, 
then chromatin was further sheared by sonication to generate DNA fragments of less 
than 0.5 kb. The resulting sonicated lysates were then used for immunoprecipitation 
with anti-RECQ1, -BLM, -WRN, -RECQ4, -RECQ5, -ORC2, -ORC1, -MCM3, -CDC6 
antibodies. A rabbit IgG was used as a negative control. Immunocomplexes were 
collected with protein A beads, washed sequentially with HNNG buffer and HLNG buffer 
(15 mM HEPES pH7.5, 250 mM LiCl, 0.5% NP-40, 10% glycerol, 1 mM PMSF), 
resuspended in TE buffer and treated with 100µg /ml RNase A (Roche) for 30 min at 
37
°
C. Samples were then incubated for 1 h at 56
°
C with 0.5 mg/ml Proteinase K (Sigma) 
and for 15 h at 65
°
C to revert the crosslink. DNA was extracted with 
phenol:chloroform:isoamyl alcohol 25:24:1 (Invitrogen), ethonol precipitated and 
resuspended in 10mM Tris-HCL, pH 7.5. 
3.5. Real-time PCR. 
The abundance of specific immunoprecipitated DNA sequences prepared as described 
above was determined by quantitative real-time PCR and/or competitive PCR. 
Sequence-specific primers for real-time PCR analysis were designed to amplify and 
detect origins as well as non-origin control regions near the human lamin B2,GM-
CSF1/2, and beta-globin replication origins (Table 1). Real-time PCR experiments were 
carried out in a total volume of 10 μl with 1 μl of genomic, nascent or 
immunoprecipitated DNA and 800 nm of primers using IQ SYBR Green Supermix (Bio-
Rad) on CFX96 Real-Time System (Bio-Rad). The amplification conditions for all primer 
sets are shown in Table 2.  Genomic DNA (100, 10, 1 ng) from crosslinked cells (input)  
was used to generate the standard curves needed for quantification of the PCR 
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products. A negative control without template DNA was included with each set of 
reactions. PCR products were also resolved on 1% agarose gels, visualized with ethidium 
bromide, no extraneous bands were generated with any of the primer sets. Enrichments 
were calculated using the  ∆∆Ct method.  
3.6. Competitive PCR.  
The abundance of two different sequences was quantified using competitive PCR. The 
sequences chosen for amplifcation are defined as B48 and B13, the B48 corresponding 
to the lamin B2 ori, whereas B13 is displaced by 5 kb. A single competitor molecule was 
used for both markers. The core of the molecule is a 110 bp region derived from the β-
globin gene harboring a 20 bp insertion. The core competitor was built directly from the 
amplification products obtained by the overlap extension method (Higuchi et al., 1988; 
Ho et al., 1989). A set of four primers was synthesized for a region of the β-globin gene. 
Two external primers (PCO3 and PCO4) were synthesized together with two internal 
primers (PCO/+1 and PCO/+2) consisting of a common 5’ tail of 20 nucleotides linked to 
the specific sequences complementary to genomic targets on the 3’ end. Pairs of 
internal and external primers were used in two separate PCR reactions for the 
construction of two intermediate products. These intermediate products were eluted 
from polyacrylamide gel, mixed, denatured and annealed. Subsequently, after one 
round of extension, the hybrid product was amplified using the external primers to 
obtain the core competitor molecule, which has the same sequence as the β-globin 
genomic target, except for the addition of 20 nucleotides in the middle. The forward and 
reverse primers spanning the lamin B2 origin area (SB12, SE10, B13, B48 see Giacca et 
al., 1994,1997), arranged in a head-to-tail fashion, were joined to the core molecule by 
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PCR amplifications, using chimerical primers. This approach allowed us to use a single 
competitor for the quantification of the relative abundance of different PCR markers. 
The competitor was quantified in competitive PCR experiments against a known amount 
of DNA molecules harboring the lamin B2 origin area. The PCR cycle profile was as 
follows: denaturation at 95°C, annealing at 56°C and extension at 72°C, time for each 
step was 30 s; 35 cycles were performed with 1 U of GO Taq polymerase (Promega). PCR 
amplified products were resolved on acrylamide gels, stained with ethidium bromide , 
intensities of the bands were quantified using ImageJ software and the ratio of 
competitor, genomic DNA were plotted in excel. 
3.7. RNA interference.  
Cells were transiently transfected for 72 h with a SMART pool siRNA against RECQ1 
(NM_032941) or RECQ4 (NM_004260) (Dharmacon) at final concentration of 100 nM by 
HiPerFect reagent (Qiagen) following the manufacturer’s instructions. RNAi control 
experiments were performed using a duplex siRNA against luciferase (Dharmacon). 
RECQ1 depletion was also obtained by transfection with the pcDNASup expression 
vector encoding a short harpin RNA against RECQ1 mRNA (target sequence: 5’-
GAGCUUAUGUUACCAGUUA-3’) using the calcium-phosphate method. The RECQ1 
downregulated clones were selected using G418 (0.5 mg/L) after 48 h of transient 
transfection followed by 2 weeks of selection.  
3.8. Colony forming assays.  
Colony forming assays were conducted as previously described (Franken et al., 2006) in 
six-well plates using glioblastoma T98G cells that had been transfected with RNAi pools 
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targeting RECQ1, RECQ4 or luciferase as a negative control. Transfected cells were 
seeded at different dilutions (200, 400, 800 cells/well). Colonies formed after growth for 
at least 7 days were counted by VersaDoc 4000 imaging system (BioRad). The colony 
forming capacity was calculated as the average ratio of the number of formed colonies 
to the number of cells seeded, expressed as a percentage.  
3.9. Nascent DNA quantitation. 
Total DNA was extracted from RECQ1, RECQ4 or luciferase RNAi- transfected T98G cells  
by standard procedures (Giacca et al., 1997), were denatured by a 10 min incubation in 
boiling water, and size-separated (300 mg per gradient) on 35 ml of 5–30% neutral 
sucrose gradients for 20 h at 26 000 r.p.m. in a Beckman SW28 rotor at 20
o
C. Fractions 
of 1 ml each were collected from the gradient and quantification of the abundance of 
the different origin and control sequences in gradient fractions was performed by 
quantitative real-time PCR analysis as described above. 
3.10. Microfluidic-assisted replication track analysis (maRTA). 
Origin firing frequency and replication fork progression rates were determined by using 
a recently described microfluidic-assisted replication track analysis protocol (maRTA) 
(Sidorova et al., 2009). In brief, RECQ1-, RECQ4- or mock-depleted T98G glioblastoma 
cells were labeled for 40 min each with 100 µM IdU followed by 100 µM CldU, then 
collected by trypsinization and used to prepare agarose plugs as previously described 
(Sidorova et al., 2009). High molecular weight labeled DNA was isolated from cells 
embedded in agarose by brief heating to 75°C to melt agarose, followed by agarase 
digestion. The resulting high molecular weight DNA was then loaded by capillary tension 
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into microchannels to uniformly stretch and capture DNA on glass coverslips for 
immunostaining and fluorescence microscopy (Sidorova et al., 2009). Origin firing 
efficiency was determined by counting the fraction of origin firing events among all 
active replication events (i.e. ongoing forks and converging forks). Replication 
elongation efficiency was determined by measuring the mean length of first label 
replication tracks in double-labelled tracks that were scored in order to unambiguously 
analyze active/ongoing forks. Track lengths were measured in digital images of tracks 
using the AxioVision software package (Carl Zeiss). Three replicate samples of RECQ1-, 
RECQ4- or mock-depleted cells were analyzed for each determination, where from 250 
to 450 replication tracks were measured in each sample.  
3.11. Biochemical fractionation.  
Biochemical fractionation was performed following a previously described procedure 
(Mendez and Stillman, 2000). To prepare total cell extracts, tissue-cultured cells were 
harvested by centrifugation, washed in PBS, and resuspended
 
in HNNG buffer followed 
by sonication for 15 s in a Tekmar
 
CV26 sonicator set at 25% amplitude samples were 
quantified by bradford reagent (Biorad) and denatured by heating 100
0
c for 5 min in 
Laemmli buffer. To prepare nuclear extracts,
 
the cells were washed once with PBS and 
lysed by Dounce homogenization
 
in hypotonic buffer (20 mM Hepes-KOH [pH 8.0], 
5 mM KCl, 1.5 mM
 
MgCl2, 5 mM Na butyrate, 0.1 mM dithiothreitol [DTT]). To isolate 
chromatin, cells were resuspended (4 × 10
7
 cells/ml) in buffer A (10 mM HEPES, [pH 7.9], 
10 mM KCl, 1.5 mM MgCl2,
 
0.34 M sucrose, 10% glycerol, 1 mM DTT, 5 µg of aprotinin 
per
 
ml, 5 µg of leupeptin per ml, 0.5 µg of pepstatin A per ml 0.1
 
mM 
phenylmethylsulfonyl fluoride). Triton X-100 (0.1%) was added,
 
and the cells were 
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incubated for 5 min on ice. Nuclei were collected
 
in pellet 1 (P1) by low-speed 
centrifugation (4 min, 1,300 × g,
 
4°C). The supernatant (S1) was further clarified by high-
speed
 
centrifugation (15 min, 20,000 × g, 4°C) to remove cell debris
 
and insoluble 
aggregates. Nuclei were washed once in buffer A,
 
and then lysed in buffer B (3 mM 
EDTA, 0.2 mM EGTA, 1 mM DTT,
 
protease inhibitors as described above). Insoluble 
chromatin was
 
collected by centrifugation (4 min, 1,700 × g, 4°C), washed once
 
in buffer 
B, and centrifuged again under the same conditions.
 
The final chromatin pellet (P3) was 
resuspended in HNNG buffer
 
and sonicated for 15 s in a Tekmar CV26 sonicator using a 
microtip
 
at 25% amplitude . 
3.12. Immunoprecipitation.  
Immunoprecipitation experiments were performed as described above for ChIP 
experiments. After washing with HLNG buffer, the sample was boiled for 30 min in SDS-
PAGE sample buffer to reverse formaldehyde cross-links. Protein samples were loaded 
and run on 8% or 10% SDS–PAGE gels prior to transfer onto PVDF or nitrocelluose 
membranes (Amersham) for Western analysis and detection by ECL (Amersham).  
3.13. Western blot analysis. 
Western blot analysis was carried out according to standard protocols. Briefly, the 
indicated amounts of whole cell extracts, chromatin-enriched fractions, cross-linked 
immunoprecipitated samples were resuspended in SDS loading buffer (50mM Tris–HCl, 
pH 6.8, 100mM DTT, 2% SDS, 0.1% bromophenol blue, 10% glycerol), boiled for 10 min 
and loaded onto a 5% stacking/8% separating SDS-PAGE gel. Following electrophoresis 
and transfer onto a PVDF membrane, the membrane was immunoblotted with the 
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indicated primary and corresponding HRP-conjugated secondary antibodies. Proteins 
were visualized using the enhanced chemiluminescence kit according to the 



















Chapter 1 : Association of RecQ helicases with human DNA replication 
origins.  
4.1.1 Chromatin immunoprecipitation of RecQ helicases 
To investigate the in vivo association of different human RecQ helicases with replication 
origins, I performed Chromatin Immunoprecipitation (ChIP) experiments. First, the 
efficiency of antibodies to immunoprecipitate the crosslinked proteins was tested by 
Western blot analysis after immunoprecipitation. Briefly, anti-RecQ helicases antibodies 
were incubated with the formaldehyde treated cell extracts and the immuno-complex 
was collected with protein A agarose beads and subjected to repeated washes, DNase 
treatment and de-crosslinking. The de-crosslinked immuno complexes were run on SDS 
page and probed with specific anti-RecQ antibodies. Western blot analysis confirmed 
the successful immunoprecipitation of all human RecQ helicases and the positive control 
ORC2 (fig.4.1.1). No specific pull down was observed with anti-IgG antibodies. 
                                                 
FIG 4.1.1: Efficiency of anti RecQ antibodies. Western analysis after immunoprecipitation of the cross-
linked material with specific antibodies against the five human RecQ proteins. ORC2-specific 
immunoprecipitation served as a positive control, and rabbit IgG immunoprecipitation served as a 
negative control. Whole T98G cell lysates (WCL) were used to confirm the endogenous expression of the 




4.1.2  Interaction of RecQ helicases with the human lamin B2 replication origin   
Following the confirmation that all anti-RecQ helicases antibodies could successfully 
immunoprecipitate their target proteins, I investigated the in vivo association of 
different RecQ helicases with the well-characterized human lamin B2 replication origin 
by ChIP and quantitative real-time PCR analysis. The lamin B2 replication origin is 
located on chromosome 19q, in the 3’- end of the lamin B2 gene and upstream of the 
promoter of the TIMM13 gene (Fig.4.1.2A). The ChIP experiments were initially done 
using asynchronous T98G human glioblastoma cells and then repeated with a normal 
human lung fibroblast cell line (IMR-90) to demonstrate that my results were not cell 
type specific. Asynchronously growing T98G/ IMR-90 cell line were treated with 
formaldehyde and the crosslinking reaction was quenched with glycine. Cross-linked 
cells were digested with with MNase to limit the size of DNA to ≤ 500bps, thus reducing 
unspecific background. The cells were lysed and sonicated. Anti-RecQ antibodies were 
added to the whole cell lysates to immunoprecipitate respective proteins. The efficiency 
of the immunorecipitation reactions was confirmed using the ORC2 antibody as positive 
control and IgG as negative control. After reversal of cross-links, the immuno-complex 
associated DNA was used for quantitative real-time PCR to determine the amount of 
origin-containing DNA bound by the immunoprecipitated protein (region B48 of the 
lamin B2 origin) compared with an adjacent region that does not contain the origin 
sequence (region B13 for the lamin B2 origin ) (Fig. 4.1.2A).  Genomic DNA prepared 
directly from crosslinked cells was used to construct the standards for real time PCR 
calibration. DNA purified from negative control IgG was used to fix the threshold. 
Analysis of the real time data was performed through  ∆∆Ct method where the 
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amplification of both the samples (B48 and B13) are normalized, then the given 
difference (delta-ct) is subtracted from the calibrator sample resulting in the delta-delta-
ct value. Results obtained from three independent analyses were shown as a fold 
enrichment of the B48 origin sequence over the B13 non-origin sequence. ChIP analysis 
showed that the origin-specific DNA was enriched three to six fold in untreated T98G 
cells relative to control sequences after immunoprecipitation with anti-RECQ1 and anti-
RECQ4 antibodies (Fig. 4.1.2B). On the other hand, I didn’t observe any enrichment for 
origin-containing regions above control levels when immunoprecipitations were 
performed with anti-BLM, anti-WRN, and anti- RECQ5 antibodies. We used the ORC2 
replication protein as a positive control in all experiments, since ORC2 has already been 
shown to bind to the lamin B2 origin (Abdurashidova et al., 2003). Consistent origin 
specific DNA enrichment was observed also in diploid fibroblast cell line established 












                                     
                            
 
FIG.4.1.2 :  RECQ1 and RECQ4 helicases are recruited to human lamin B2 origins of DNA replication. (A 
and B) Genomic regions containing the laminB2 origin (A) are shown together with the locations of sets of 
primers (converging arrow pairs) used for quantitative real-time PCR analysis. (B) Quantification of cross-
linked lamin B2 origin DNA immunoprecipitated by ChIP from T98G and IMR-90 cells, using the antibodies 
indicated at the bottom. Fold enrichments of origin sequences were determined versus nonorigin control 
sequences, and the dashed line indicates the threshold enrichment level obtained by using a negative-
control antibody (normal rabbit IgG). Results are reported as means ± standard errors of the means (SEM) 








4.1.3. Interaction of RecQ helicases with the lamin B2 replication origin by competitive 
PCR analysis  
The results of the real-time PCR analysis were also confirmed by competitive PCR 
experiments in which the amount of origin sequence was estimated by comparing the 
intensities of corresponding amplified bands to those of bands generated from known 
amounts of competitor present in the same reaction tubes. Quantification was done by 
adding scalar quantities of competitor and a fixed quantity of immuno purified DNA (Fig. 
4.1.3A). The competition samples after PCR amplification were run on TBE acrylamide 
gels, stained with ethidium bromide and the intensities of the bands were measured 
with the image J software. The values obtained were then plotted as a function of the 
log10 of the known competitor DNA copy number. The point of equivalence 
corresponds to the point where the amounts of the competitor and target were equal, 
and represented the number of copies of B48 origin sequence and B13 non-origin 
sequence in the starting sample. This procedure provides an additional level of 
specificity and gives more sensitive quantification.  
         Competitive PCR quantification confirmed the enrichment of human lamin B2 
origin sequences in the immunoprecipitations with anti-RECQ1 and anti-RECQ4 
antibodies (Fig. 4.1.3A). Origin-specific DNA was enriched four- to five fold in untreated 
T98G cells relative to control sequences after immunoprecipitation with anti-RECQ1 and 
anti-RECQ4 antibodies. Conversely no such enrichments was observed with anti-BLM, 














FIG.4.1.3 : Analysis of the association of RECQ1 and RECQ4 with the human lamin B2 replication origin 
by competitive PCR. A) Gel photos show the results of quantitative competitive PCR analysis performed 
using ChIP samples prepared by immunoprecipitation with antibodies against the five human RecQ 
enzymes or with ORC2 protein or normal rabbit IgG as positive and negative controls, respectively. A 
typical competitive PCR experiment is performed by addition of scalar amounts of competitor (C) of 
known concentration to a fixed amount of the genomic DNA (G) to be quantified. The amplification 
products are resolved by gel electrophoresis, stained with ethidium bromide, and quantified as previously 
described (Abdurashidova et al., Embo J.2003). B) The bar graph quantifies cross-linked lamin B2 DNA 
immunoprecipitated by ChIP using antibodies specific to the proteins shown across the bottom. Fold 
enrichments of origin sequences were determined versus non-origin control sequences, and the dashed 
line indicates the threshold enrichment level obtained by using a negative control antibody (normal rabbit 
IgG). Results are reported as means ± SEM (standard error of the mean, indicated by error bars) of at least 









4.1.4  Interaction of RecQ helicases with human GM-CSF replication origins   
The interaction of the human RECQ1 and RECQ4 helicases with the lamin B2 replication 
origin was confirmed using two addition origin sequences. These two origins (GM-CSF 
Ori1 and Ori2) are located 5 kb apart and  approximately 5 kb downstream of the 3’ end 
of the GM-CSF gene, on chromosome 5q, and were shown to interact with different 
members of the DNA pre-replication complex (Fig. 4.1.5A). These two origins are fully 
competent to direct the assembly of a pre-RC and to drive initiation of DNA replication. 
They lie in an intergenic region and are neither associated with a promoter, nor linked to 
a CpG island, and do not share sequence similarity to other known origins (Todorovic et 
al., 2005). ChIP experiments were done using asynchronous T98G human glioblastoma 
cells. Origin specific DNA (17 for GM-CSF Ori1 and 23 for GM-CSF Ori2) was enriched 
approximately four- to five fold in comparison with nonorigin sequence (region 21) in 
the immuno-purified DNA obtained with RECQ1 and RECQ4, respectively. Consistent 
with my lamin B2 origin observations, RECQ1 and RECQ4 were the only two RecQ 
helicases associating with GM-CSF Origins. Immuno-purified DNA from BLM, WRN and 
RECQ5 showed no specific enrichment of GM-CSF1 and GM-CSF2 origin sequences in 
relation to nonorigin sequences (Fig. 4.1.5B). 
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FIG. 4.1.4: RECQ1 and RECQ4 helicases are recruited to human GM-CSF1 and GM-CSF2 origins of DNA 
replication. (A) Genomic regions containing the two GM-CSF replication origins  are shown with the 
locations of sets of primers (converging arrow pairs) used for quantitative real-time PCR analysis.  
(B) Quantification of cross-linked GM-CSF1 and GM-CSF2 origin DNAs immunoprecipitated by ChIP from 
T98G cells, using the antibodies indicated at the bottom. Fold enrichments of origin sequences were 
determined versus nonorigin control sequences, and the dashed line indicates the threshold enrichment 
level obtained by using a negative-control antibody (normal rabbit IgG). Results are reported as means  ± 










4.1.5. Interaction of RecQ helicases with human Lamin B2 replication origin in 
replication perturbed cells 
The origin specific interaction of only two human RecQ helicases in unperturbed cells, 
raised the question whether the same behavior would be observed upon replication 
stress induciton. Thus, the same ChIP experiments were repeated in the presence of the 
replication inhibitor hydroxyurea (HU). HU induces DNA damage leading to stalled or 
reduction in the speed of replication fork movements. Briefly, T98G cells were treated 
with 2mM HU overnight and ChIP experiments were repeated with anti RecQ 
antibodies.  
         Treatment with HU showed that all five human RecQ helicases, including RECQ1 
and RECQ4, interacted with the lamin B2 origin upon replication stress (figure 4.1.6). It 
has been shown that BLM and WRN relocalizes from PML bodies to replication sites 
upon treatment with replication inhibitors and they accumulate at replication foci either 
to restart or to repair the stalled forks. My observation that BLM, WRN and RECQ5 
interacts with the replication origins in HU treated cells provides further support for the 
proposed roles of these helicases in promoting fork recovery or repair (Fig. 4.1.6). 
However, my results indicate that of the five human RecQ helicases, only RECQ1 and 
RECQ4 specifically bind replication origin regions in unperturbed cells, and that origin 
binding is not origin or cell type specific, suggesting that these two RecQ helicases are 
required during normal replication, whereas BLM, WRN, RECQ5 might be needed under 









                        
 
 
FIG.4.1.5: Comparison of association of RECQ1 and RECQ4 helicases with the lamin B2 origin in 
untreated versus HU-treated cells.T98G cells were treated with 2 mM HU for 24 h. The bar graph shows 
the quantification of cross-linked lamin B2 origin DNA immunoprecipitated from T98G glioblastoma cells, 
using antibodies specific to the proteins shown across the bottom. Fold enrichments of origin sequences 
were determined versus nonorigin control sequences, and the dashed line indicates the threshold 
enrichment level obtained by using a negative-control antibody (normal rabbit IgG). Results are reported 




















4.1.6. Interaction of BLM complex proteins with human lamin B2 replication origins 
The interaction of BLM, WRN and RECQ5 with the human lamin B2 replication origin in 
replication perturbed cells indicates that these helicases may regulate origin activity 
when cells are under replication stress. Protein partners of RecQ helicases may also be 
required to regulate the origin activity. Consistent with this hypothesis, cells lacking 
RMI1 or Rif1, two recently discovered protein partners of BLM, are sensitive to 
hydroxyurea treatment. To check the hypothesis that these BLM complex components 
participate in modulating origin activity we performed ChIP with Rif1 and RMI1 in 
unperturbed and hydroxyurea treated cells (Fig.4.1.7A). Both Rif1 and RMI1 immuno-
purified DNA showed no specific enrichment of origin sequences in unperturbed cell 
lines. However, Rif1 and RMI1 showed approximately five-to six fold enrichments, 
respectively, when the cells were treated with hydroxyurea (Fig.4.1.7B). Rif1 and RMI1 
followed the same behaviour of BLM in both unperturbed and perturbed cell lines. TBE-
PAGE analysis of real time PCR end product revealed a clear enrichment of origin 
sequences in immuno-purified DNA of BLM, Rif1 and RMI1, obtained from hydroxyurea 
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FIG.4.1.6: Comparison of association of BLM comples proteins  with the lamin B2 origin in untreated 
versus HU-treated cells. A) Western blot analysis after immunoprecipitation of cross-linked material with 
anti-BLM, anti-Rif1, anti-RMI1 antibodies. Whole T98G cell lysates (WCL) used to confirm the exogenous 
expression, and mouse IgG immunoprecipitation served as negative control. B) T98G cells were treated 
with or without 2 mM HU for 24 h. The bar graph shows the quantification of cross-linked lamin B2 origin 
DNA immunoprecipitated from T98G glioblastoma cells, using antibodies specific to the proteins shown 
across the bottom. Fold enrichments of origin sequences were determined versus nonorigin control 
sequences, and the dashed line indicates the threshold enrichment level obtained by using a negative-
control antibody (normal rabbit IgG). Results are reported as means  ±  SEM for at least three independent 
experiments. C) TBE-PAGE analysis of PCR products obtained hydroxyurea treated (+) and mock treated (-) 






Chapter 2: Regulation of RECQ1 and RECQ4 association with human DNA 
replication origins. 
4.2.1 Cell cycle regulated expression of RECQ1 and RECQ4 helicases 
          My finding that RECQ1 and RECQ4 associate with DNA replication origins raises the 
possibility that the interaction of these two helicases may be cell cycle regulated. In 
order to address this possibility, I tested the expression of RECQ1 and RECQ4 during cell 
cycle. I used the T98G cell line, because T98G cells could be efficiently synchronized by 
serum deprivation (Takahashi et al., 2000). Although it is a continuous cell line, T98G has 
retained growth arrest mechanisms characteristic of normal cells, including density 
mediated growth inhibition and induction of quiescence in response to serum 
deprivation (Stein, 1979). Serum starvation resulted in the accumulation of a quiescent 
population G0 that synchronously progressed through G1 and S phase after serum 
stimulation (Fig. 4.2.1A), allowing for the isolation of populations in early G1 (8 h), mid-
G1 (12 h), late G1 (18 h), at the G1/S transition (20 h), early S (22 h), mid S (24 h), and in 
G2/M phase (28 h) (henceforth, all cell cycle phase designations refer to these time 
points). Synchronization and cell cycle progression were monitored by fluorescence-
activated cell sorter (FACS) analysis and by western analysis of cyclin E and cyclin A1 
expression (Fig. 4.2.1A and 4.2.1B). In agreement with previous findings, cyclin E and 
cyclin A1 protein levels started to rise in middle G1 (12 h) and early S (22 h), 
respectively, while both cyclins were present at the G1/S boundary (20 h) (Mailand and 
Diffley, 2005). RECQ1 was present throughout synchronization and release, with a small 
but reproducible increase at the G1/S border (20 h), a pattern similar to, though not as 
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pronounced as, that observed for cyclin A1. In contrast, RECQ4 was almost undetectable 
in G0 or resting cells but was readily detectable in late G1 and early S (18 h) (Fig. 4.2.1B). 
                                
 
                                
FIG.4.2.1: Cell cycle-dependent expression of RECQ1 and RECQ4 helicases. (A) Cell cycle phase timing 
was determined by flow cytometry profiling of synchronized T98G cells that had been cultured without 
serum for 72 h and then sampled over a 28-h time course after the addition of serum. PI, propidium 
iodide. (B) Western blot analysis of whole-cell extracts of asynchronous T98G cells (AS) or cells from 










4.2.2 Cell cycle regulated interaction of RECQ1 and RECQ4 helicases with replication 
origins 
Following my observation that RECQ1 and RECQ4 expressions are cell cycle regulated, I 
tested if the association of these RecQ helicases with replication origins is also changing 
as a function of the cell cycle. In order to address this possibility, I used ChIP analyses to 
determine whether RECQ1 or RECQ4 was recruited to origins in a cell cycle phase-
dependent fashion. ChIP experiments from synchronized T98G cells showed that neither 
RECQ1 nor RECQ4 was associated with replication origins in G0 or early G1. A threefold 
enrichment of RECQ4 binding to the lamin B2 origin region could be detected at the 
G1/S boundary and increased to approximately six fold above background with the 
onset of S phase (Fig.4.2.2). Conversely, RECQ1 was found enriched at origin sequences 
only in early S. For comparison, ORC2, a well-characterized component of the pre-
replication complex (pre-RC), was found on origin regions in early G1 and remained 







                          
 
FIG.4.2.2 : Cell cycle-dependent association of RECQ1 and RECQ4 with the human lamin B2 replication 
origin. Quantification of cross-linked lamin B2 origin DNA immunoprecipitated by ChIP from synchronized 
cells. The key on top indicates the antibodies used for ChIP analyses. Fold enrichments of lamin B2 origin 
region (B48) DNA over control B13 region DNA are reported for each antibody, where the dashed line 
indicates the threshold enrichment obtained using a negative-control normal rabbit IgG antibody. 
Histogram bars report the mean ±  SEM for at least three independent experiments for each antibody and 
cell cycle fraction. 
 
 
4.2.3. Analysis of RECQ1 and RECQ4 association with replication origins in mimosine 
blocked cells. 
My analysis of RECQ1 and RECQ4 loading to the replication origins in the synchronized 
cells revealed RECQ4 loads to the origins before RECQ1. To confirm the loading of 
RECQ4 to replication origins precedes RECQ1 loading, asynchronously growing T98G 
cells were treated with mimosine. The plant amino acid mimosine has been 
demonstrated to arrest cell cycle progression in late G1 (Tsang et al., 2007). FACS 
analysis confirmed the accumulation of late G1 cells by mimosine treatment (Fig. 
4.2.3A). ChIP of mimosine treated T98G cells showed two fold enrichment of origin 
specific sequences from RECQ4 immunoprecipitated DNA but not with RECQ1 
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immunoprecipitated DNA. ORC2, the positive control, showed consistent enrichment of 
origin sequences in the immunoprecipitated DNA  (Fig. 4.2.3B). My observation that 
RECQ4 is loaded onto the origins in late G1 suggests that RECQ4 could be a new member 






FIG 4.2.3: Recruitment of RECQ4 to replication origins precedes RECQ1 loading. A) FACS profile 
showing T98G cells were synchronized in late G1 by mimosine treatment for 24 h. B) Synchronized cells 
were used to quantify proteins cross-linked to the lamin B2 origin DNA that could be immuno-precipitated 
by antibodies specific to the proteins indicated at the bottom. The bargraph shows fold enrichments of 
origin sequences versus non-origin controlsequences, where the dashed line again indicates the threshold 
enrichment level obtained byusing a negative control antibody (normal rabbit IgG). Results are reported 










4.2.4. Sequential loading of RecQ helicases on replication origins: a detailed analysis. 
To better define the temporal loading of the human RECQ1 and RECQ4 helicases on the 
replication origin, a detailed analysis of the cell cycle-dependent association of RECQ4, 
RECQ1, and other known replication factors with the lamin B2 origin was tested by ChIP 
experiments. T98G cells were synchronized by serum starvation and the cells 
representing late G1, G1/S, early S, mid S and late S were collected. Synchronization was 
confirmed by FACS profile. Western blot analysis of cyclin expression pattern in the 
synchronized cells was consistent with prior literature (Mailand and Diffley, 2005), 
confirming again the effective synchronization (Fig.4A.2.4B). Through my ChIP 
experiments I found, consistent with published results, that CDC6, ORC1, ORC2, and 
MCM4 assembled on the origin in G1 to complete the prereplication complex 
(Abdurashidova et al., 2003; Ghosh et al., 2006; Schaarschmidt et al., 2002). RECQ4 
loading was detected in late G1 as part of the prereplication complex and was most 
abundant at the G1/S border as CDC6 was lost. In early S phase, ORC1 was also lost from 
origins, as expected (Abdurashidova et al., 2003), whereas RECQ1 and additional RECQ4 
could now be detected on the lamin B2 origin. RECQ4, RECQ1, and MCM4 binding to the 
origin region of lamin B2 was no longer detectable after mid-S phase (Fig.4.2.4). In 
agreement with my findings, a recent study showed that a Flag-tagged version of RECQ4 
specifically interacted with the lamin B2 origin during the G1 and S phases of the cell 
cycle in human 293T cells (Xu et al., 2009a). In this analysis, the lamin B2 origin 
appeared to be enriched five-fold at G1 compared with S phase. These results are 
difficult to assess in the absence of detailed ChIP analysis time course data. The 
apparent enrichment in origin binding at G1 versus S may reflect the fact that the 
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sample used for S-phase experiments corresponded to mid or late S, as suggested from 
the flow cytometry data, where I showed that RECQ4 was almost undetectable on the 
lamin B2 origin. Collectively, my results and those reported by Xu et al (Xu et al., 2009a), 
indicate that RECQ4 is part of the prereplication complex and thus might play a role in 
the transition from the prereplication to the preinitiation complex. RECQ1, in contrast, 
may be assembled on origins only at the start of bidirectional DNA synthesis. The 
subsequent loss of both RECQ1 and RECQ4 from origin regions could indicate either 
disassembly or the tracking of one or both RecQ helicases with the newly formed 














   
 
 
                                 
                                       
FIG.4.2.4 : G1- and S-phase-specific loading of RECQ4 and RECQ1 on the lamin B2 origin. A) Paired 
columns show flow cytometry profiles of synchronized T98G cells at different times after release from 
serum starvation, together with bar graphs of cross-linked lamin B2 origin DNA immunoprecipitated by 
ChIP with antibodies to each of the proteins shown across the bottom of the bar graph at that time point. 
Histograms report  the mean ±  SEM for at least three independent experiments at each time point, where  
fold enrichments of lamin B2 origin region (B48) DNA over control B13 region DNA are reported for each 
antibody, where the dashed line indicates the threshold enrichment obtained using anegative-control 
normal rabbit IgG antibody. B) Western blot analysis of whole-cell extracts of  T98G cells (AS) or cells from 







4.2.5 Cell cycle regulated chromatin association of RECQ1 and RECQ4 helicases 
Since the early S phase specific cellular upregulation of RECQ1 and the late G1 
expression of RECQ4 are in accordance with the cell cycle dependent origin loading of 
these proteins, I investigated whether such a cell cycle specific origin association is also 
regulated at subcellular level. To examine this, I synchronized and collected cells 
representing various phases of the cell cycle. These cells were then fractioned into 
cytoplasmic (S2), nucleoplasmic (S3) and chromatin enriched (P3) fractions. Western 
analysis was performed with the biochemically fractioned, synchronized cells. Tubulin 
served as a control for cytoplasmic fractionation and also as a loading control of 
cytoplasmic fractions, whereas p84 served as a control for chromatin fractionation. In 
agreement with the ChIP results, biochemical fractionation experiments showed that 
RECQ4 was enriched in the chromatin fraction during the late G1 and early S phases (Fig 
4.2.5). The continued presence of RECQ4 bound to chromatin in late S is consistent with 
the idea that RECQ4 might leave origin regions to travel with the replisome after 
replication initiation. Although most of the RECQ1 protein was bound to chromatin 
throughout all phases of the cell cycle, ChIP experiments showed that RECQ1 interacted 
with replication origins only at the onset of S phase, when origins are licensed for firing. 
Interestingly, the partitioning of RECQ1 and RECQ4 between cytosolic and 
nucleoplasmic fractions changed over the cell cycle. This suggests that RECQ1 and 
RECQ4 function might be regulated by a combination of cell cycle-dependent synthesis 
and subcellular localization (Fig 4.2.5). This cell cycle dependent sub-cellular localization 
correlated well with the origin loading and thus appear to support the notion that the 





          
 
FIG 4.2.5: Cell cycle-dependent subcellular distribution of RECQ1 and RECQ4. Whole-cell lysates were 
fractionated to generate cytosolic (S2), soluble nuclear (S3), and chromatin-enriched (P3) fractions, in 
which protein levels were assessed by Western blotting. Antibodies against p84 and  α-tubulin were used 













4.2.6. Analysis of the replication timing-regulated association of RECQ1 and RECQ4 
with replication origins. 
The lamin B2 and GM-CSF origins are early firing DNA replication origins (Abdurashidova 
et al., 2000; Todorovic et al., 2005). To test if the temporal loading of RECQ1 and RECQ4 
to replication origins might change as a function of replication timing, I compared the 
loading of these two helicases on the human beta-globin replication origin in HeLa 
versus K562 cell lines in ChIP experiments (Fig.4.2.6A). The beta-globin origin is located 
on chromosome 11, in the region encompassing the human beta-globin gene, and it is 
known to replicate in early S phase in hematopoietic cells (K562 cells) and later in S in 
non hematopoietic cells (HeLa cells) (Buzina et al., 2005; Epner et al., 1988; Kitsberg et 
al., 1993). The K562 and HeLa cell lines were synchronized by mimosine treatment in 
late G1 and then released from the drug and harvested at different time points during S 
phase. Cellular synchronization and progression were monitored by FACS analysis 
(Fig.4A.3B and Fig.4A.3C). Control experiments confirmed that RECQ1 and RECQ4 were 
enriched at the lamin B2 origin sequence in early S and were lost from the lamin B2 
origin in late S in both cell lines. These results support my previous conclusion that the 
interaction of RECQ1 and RECQ4 with the early-firing lamin B2 origin is not cell type 
specific (Fig.4.2.6B and Fig.4.2.6C). My results using the beta-globin origin in K562 cells 
showed that the timing of the interaction of RECQ1 and RECQ4 was identical to what I 
observed for the lamin B2 origin (Fig.4.2.6B). Conversely, in HeLa cells, where beta-
globin origin firing occurs later during S, RECQ1, RECQ4, and ORC2 were already 
detected on the origin in early S and remained bound in late S (Fig.4.2.6C). The presence 
of origin-bound RECQ1, RECQ4, and ORC2 already in early S phase indicates that the 
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temporal loading of these factors is likely to be independent of origin replication timing. 
These results suggest a model in which replication factors assemble on most or all 
origins during G1/early S, when cyclin-dependent kinase levels are permissive, but that 
further signals are necessary to start replicating at a specific point in S phase. Further 
analyses will be required to test this model. 
                                
FIG.4.2.6: Association of RECQ1 and RECQ4 with beta-globin replication origin as a function of origin 
timing. (A) Genomic region containing the beta-globin replication origin, together with the locations of 
sets of primers (converging arrow pairs) used for quantitative real-time PCR analysis. (B) Flow cytometry 
profiling of synchronized K562 cells that had been cultured with mimosine for 24 h and then sampled 3 
(early S) and 9 (late S) h after the removal of the drug is shown at the top. The histograms below quantify 
cross-linked lamin B2 and beta-globin origin DNAs immunoprecipitated by ChIP from early- and late-S-
phase-synchronized K562 cells. (C) Flow cytometry profiling of synchronized HeLa cells that had been 
cultured with mimosine for 24 h and then sampled 3 (early S) and 9 (late S) h after the removal of the drug 
is shown at the top. The histograms below quantify cross-linked lamin B2 and beta-globin origin DNAs 
immunoprecipitated by ChIP from early- and late-S-phase-synchronized HeLa cells. Histograms report the 




Chapter 3: Physiological role of RECQ1 and RECQ4  
4.3.1.  Analysis of proliferation capacity of RECQ1- and RECQ4-depleted cells. 
To elucidate the physiological role of RECQ1 and RECQ4, I analysed the replication 
phenotype of cells where RECQ1 and RECQ4 were depleted. T98G glioblastoma cells 
were transfected with RECQ1, RECQ4, or luciferase (mock-depleted control cells) siRNA. 
Western blot verification of the extent of depletion indicated marked or near-complete 
depletion of RECQ1 and RECQ4, respectively (Fig. 4.3.1B). Consistent with the idea that 
RECQ1 and RECQ4 may play a role in DNA replication initiation, I observed a significant 
reduction in cell proliferation following the siRNA-mediated depletion of RECQ1 or 
RECQ4 from T98G cells In particular, I compared the colony forming properties of T98G 
glioblastoma cells transfected with RECQ1 or RECQ4 siRNA versus a T98G cell line 
transfected with a control siRNA against luciferase (mock-depleted control cells). 
RECQ1-and RECQ4-depleted T98G cells showed, respectively, a 5-fold and 6-fold 
reduction in proliferation as measured by colony formation versus mock-depleted 
control cells (Fig.4.3.1A). My observation that RECQ1 and RECQ4 were important for cell 
proliferation was consistent with the recent reports (Futami et al., 2008; Sangrithi et al., 
2005; Sharma and Brosh, 2007). The same experiment repeated with the human 
GM00637 SV40 fibroblast cell line indicated that RECQ1 and RECQ4 depletion were 
growth suppressive, and that the effect of RECQ1 or RECQ4 depletion was not cell type-




                 
Figure 4.3.1: Down-regulation of RECQ1 and RECQ4 inhibits cellular proliferation.  A) Colony forming 
efficiency of T98G cells after siRNA-mediated transfection. Plate photos show representative colony 
formation after plating cells transfected with siRNA pools directed against the gene named across the top. 
Cell number plated is indicated by the code along the left: I: 200 cells/well; II: 400 cells/ well; III: 800 
cells/well. Colonies were stained and counted after 7 days of growth and counted to determine colony 
forming efficiencies that are summarized in the bar graph that summarizes results (mean ± SEM) of three 
independent experiments. B) Western blot analysis of RNAi-mediated depletion of RECQ1 or RECQ4 from 
T98G cells transfected with siRNA pools against RECQ1, RECQ4 or luciferase (Luc) at 72 h post-
transfection. α-tubulin was used as a blot control. 
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4.3.2. Analysis of cell cycle progression and DNA synthesis in RECQ1- and RECQ4-
depleted cells. 
To further address the physiological role of RECQ1 and RECQ4’s and futher investigate 
the possible reason of the cell proliferation defects of RECQ1 and RECQ4 depleted cells, I 
studies tha cell cycle kinetics of RECQ1, RECQ4, and luciferase downregulated cells. 
Thus, I found a greater fraction of cells in late G1 both in RECQ1 and RECQ4 depleted 
cells, suggestive of delayed S phase progression. To obtain more detailed information of 
potential replication defects, I quantitatively monitored the degree of 
bromodeoxyuridine (BrdU) incorporation. FACS analysis of RECQ1- or RECQ4-depleted 
cells that had been BrdU -labelled, demonstrated a >50% reduction in both BrdU 
labelling and S phase fraction together with an increased G1 fraction versus controls 
(Fig.4.3.2). These results were consistent with previous reports of an increased G1 
fraction and decreased BrdU incorporation in RECQ4-depleted cells (Sangrithi et al., 
2005). Similar results were again obtained using RECQ1- or RECQ4-depleted GM00637 
fibroblasts (data not shown). These results demonstrate that RECQ1 or RECQ4 depletion 











Figure 4.3.2: Down-regulation of RECQ1 and RECQ4 inhibits DNA synthesis.  Flow cytometry profiles 
plotting DNA content on the x-axis (propidium iodide/PI staining) versus BrdU incorporation on the y-axis 
as detected by anti-BrdU immunostaining at 72 h after siRNA transfection. Boxes are labeled to indicate 
cell cycle phases where the mean percent S-phase cells is shown in parenthesis across the top of each 
histogram. The bar graph at bottom reports the percentage of G0/G1, S-phase/BrdU positive and G2/M 
cells in cultures that had been transfected with RECQ1, RECQ4 or luciferase/control siRNA pools (indicated 









Chapter 4: Functional characterisation of the role of RECQ1 and RECQ4 in  
DNA replication. 
4.1. Nascent DNA analysis 
In order to functionally characterise the role of RECQ1 and RECQ4 helicases in DNA 
replication and to determine whether reduced BrdU incorporation and proliferation of 
RECQ1- or RECQ4-depleted cells reflected impaired DNA replication initiation, I 
quantified nascent DNA production from origins in RECQ1- and RECQ4-depleted cells. 
The nascent DNA assay used quantitative real-time PCR to measure newly synthesized 
DNA corresponding to the lamin B2 origin and the GM-CSF Ori1 and Ori2 regions in 
neutral sucrose gradient centrifugation fractions from RECQ1- and RECQ4-depleted cells 
(Giacca et al., 1994). Thus, I found that origin sequence DNA was reduced by 
approximately 50% in RECQ1-depleted cells, and by >90% in RECQ4-depleted cells 72 h 
after siRNA transfection (Fig. 4.4.1). The reduced nascent DNA in RECQ1 and RECQ4 
downregulated cells suggests that both RECQ1 and RECQ4 are involved in the initiation 






















Figure 4.4.1: RECQ1 and RECQ4 depletion reduces newly synthesized nascent DNA from early firing 
human replication origins. A,B) Figures across the top of each column depict the human lamin B2 (A) and 
two GM-CSF (B) replication origin regions and the locations of primer pairs used to monitor origin- and 
adjacent non-origin sequences. Graphs below each figure show the fold enrichment in nascent DNA from 
origin regions versus adjacent non-origin regions in neutral sucrose gradient fractions prepared from T98G 
cells depleted of RECQ1 (middle row) or RECQ4 (bottom row) by RNAi transfection compared with control 





4.2. Analysis of replication origin use and fork progression rate. 
The sequential loading of RECQ4 and RECQ1 on origins at different times after pre-
replicative complex (pre-RC) formation suggests these two proteins may play distinct 
roles during or after replication initiation. In order to gain more insight into these roles 
of RECQ1 and RECQ4, I performed replication track analyses on DNA from T98G cells 
transfected with RECQ1 or RECQ4 siRNA. These experiments were peformed in 
collaboration with the group of Prof. Raymond Monnat from the Universirt of Seattle 
(USA). In these experiments, cells were labelled sequentially for 40 min each with IdU 
and with CldU, and genomic high molecular weight DNA was isolated and stretched with 
the aid of microfluidic channels for replication track analysis (Fig.4.4.2) (Sidorova et al., 
2008; Sidorova et al., 2009).   
To evaluate origin firing efficiency, I estimated the fraction of origin firing events 
among all replication events during the 80 min labeling period. The origin firing events 
corresponded to tracks containing CldU only or a central IdU segment flanked by two 
CldU segments. Other ongoing replication events were elongating forks (IdU-CldU 
tracks) and converging forks (IdU-CldU-IdU tracks). This analysis revealed that RECQ1 or 
RECQ4 depletion reduced the probability of origin firing during the labeling period from 
20% (in luciferase controls) to approximately 14 and 12% respectively (Fig. 7B). These 
results were consistent with my nascent DNA assay results, and indicate that 
RECQ1─and to a greater extent RECQ4─are important for efficient replication initiation. 
I also determined whether replication elongation was affected in RECQ1- or RECQ4-
depleted cells. I measured the lengths of IdU segments in ongoing forks represented by 
two-segment (IdU-CldU) tracks. Interestingly, this analysis showed that in RECQ1─but 
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not RECQ4─depleted cells, first label segments were significantly (p<0.001) shorter than 
in control cells (Fig.4A.7C). Lengths of second label CldU segments in these same tracks 
were also shorter, as were CldU-only tracks in RECQ1-depleted cells (data not shown). 
These data suggest that RECQ1 may play an additional role in maintaining replication 












                            
 
Figure 4.4.2: Depletion of human RECQ1 or RECQ4 affects DNA replication dynamics. A) An outline of 
the experimental protocol is shown on top, in which asynchronous cells were labeled consecutively with 
IdU (green), then with CldU (red) for 40 min each prior to isolating and stretching DNA for immunostaining 
as described in Methods. Shown below this are representative images of replication tracks in control 
(luciferase-), RECQ1- or RECQ4-depleted cells. All track photos are shown at identical magnification, 
where the white scale bar (lower left) is 10 um long representing approximately 30 kb of DNA or 20 
minutes of replication fork progression. B) RECQ1 or RECQ4 depletion reduces the probability of origin 
firing in stretched DNA samples. Origin firing events among all tracks labeled during the protocol shown in 
A) were identified as CldU-only (red only) or CldU-IdU-CldU (red-green-red) triple-segment tracks (see 
diagram at top). The mean percentage of new origin firing events defined by these two track types among 
all labeled tracks is shown for three independent experiments in which 200 - 450 tracks/experiment were 
typed for control-, RECQ1- or RECQ4-depleted cells. Error bars are standard deviations. The p values 
calculated using Student's t-test are: p = 0.074 between luciferase and RECQ1, and p = 0.021 between 
luciferase and RECQ4. C) RECQ1 depletion, but not RECQ4 depletion, slows ongoing replication forks. The 
bar graph summarizes mean lengths of first-label IdU (green) segments labeled for 40 min in two-segment 
(green-red) tracks to ensure fork rate measurements were made from active replication forks (see A 
diagram above). Track lengths in um were measured using AxioVision Software (Carl Zeiss) for three 
independent experiments, where 150 - 370 first segment track lengths were measured for each sample. 
Error bars show 95% confidence intervals for sample means. The statistical significance of differences in 
mean track lengths was determined by a 2-sample Kolmogorov-Smirnov test. A representative p value is 








4.3. Analysis of chromatin loading of replication factors 
In order to provide additional mechanistic insight into the replication role of RecQ 
helicases, I also examined the order of chromatin loading of replication factors in 
RECQ1- or RECQ4-depleted T98G cells at the onset of S phase. Cells were synchronized 
by serum starvation in G0 prior to release by the addition of serum and concurrent 
transfection with RECQ1 or RECQ4 siRNA (Fig. 4.4.3A). Cells were harvested 24 h after 
serum stimulation and transfection in order to isolate cell populations highly enriched in 
S phase. The S phase synchronized luciferase siRNA transfected, RECQ1 siRNA 
transfected and RECQ4 siRNA transfected cells were biochemically fractioned to 
cytoplasmic (S2), nucleoplasmic (S3) and chromatin enriched (P3) fractions as described 
previously (Mendez and Stillman, 2000). Using this protocol I could achieve >90% RECQ4 
depletion, and marked though less efficient depletion of RECQ1 consistent with our 
previous observation that RECQ1 is already expressed in G0 (Fig.4.4.3B). My results 
showed RECQ1 and RECQ4 depletion had no effect on the chromatin recruitment of 
MCM3 and ORC1. This suggests that RECQ1 and RECQ4 are loaded on origins after 
assembly of the pre-replication complex (Fig.4.4.3B).  In contrast, the recruitment of 
PCNA to chromatin was decreased in RECQ1-depleted─and more markedly in RECQ4-
depleted─cells, while RPA loading was suppressed only in RECQ4-depleted cells (Fig. 
4.4.3B). These results suggest that RECQ4 is loaded onto chromatin and origins before 






                               
 
Figure 4.4.3: RECQ1 and RECQ4 depletion impairs replication factor loading onto chromatin at the 
start of S phase. A) Experimental outline for synchronization and release of human T98G cells to generate 
highly enriched S-phase progressing fractions. Asynchronous cells were grown for 72 h without serum, 
then refed, RNAi-transfected, and harvested after 24 h for blot analysis. B) Western blot analysis of whole 
and fractionated cell extracts from synchronized T98G cells. Left and right panels show the subcellular 
distribution of  RECQ1 (left column top), RECQ4 (right column top), and four additional replication 
proteins together with an α-tubulin control (both columns) in whole cell lysates (WCL) and in cytosolic 
(S2), soluble nuclear (S3) and chromatin-enriched (P3) fractions prepared from RECQ1-, RECQ4- or control 















4.4. Model of cell-cycle dependent loading of RECQ1 and RECQ4 proteins onto DNA 
replication origins. 
Based on the results of the ChIP analysis (4.2.4), I drew a model of DNA replication 
including two new proteins, RECQ1 and RECQ4. In this model, RECQ4 associates with 
replication origins during the late G1 phase of the cell cycle, when pre-RC complex 
formation takes place, and it remains bound to origins until mid S phase. RECQ1 loads to 
the origin after RECQ4 during early S phase of the cell cycle and remains at origins until 
mid S phase (Fig.4.4.4). The possible roles of these two RecQ helicases in DNA 
















                                 
 
Figure 4.4.4: Model of cell-cycle dependent loading of RECQ1 and RECQ4 proteins onto DNA 
replication origins. RECQ4 is recruited to origins in late G1 as part of pre-replicative complex (Pre-RC) 
assembly. At the G1/S transition CDC6 release signals pre-initiation complex (Pre-IC) formation. RECQ1, as 
well as additional RECQ4, are recruited in early S-phase after the release of ORC1. Both RECQ1 and RECQ4 
are no longer detectable on the lamin B2 origin by mid-S-phase, when either or both may be associated 
with active replisomes. This cell cycle phase dependent loading and subsequent loss of RECQ1 and RECQ4 
for origins of replication suggest specific roles for each protein in replication initiation and, potentially, 





DNA replication is a tightly regulated process essential for the faithful transmission of 
genetic information in all living organisms (Blow and Ge, 2009; Diffley, 2004; Friedel et 
al., 2009). Given the centrality of replication, it is not surprising that cells have evolved 
complex mechanisms to regulate DNA replication origin firing and fork progression, as 
well as a variety of pathways to prevent replication defects, repair damaged replication 
forks, and enable fork reactivation. The different cellular and DNA metabolic defects 
associated with loss of RecQ helicase function in many organisms suggest that the five 
human RecQ helicases play important and probably distinct roles in DNA replication. 
However, the nature and mechanistic details of these roles remain controversial.  
          My work extends existing knowledge of the role of specific human RecQ helicase 
proteins in DNA replication. I found that only two of the five human RecQ helicases, 
RECQ1 and RECQ4, bind specifically in vivo to three well-defined human replication 
origins in unperturbed cells (Fig 4.1.2). RECQ4 is bound to origins in late G1, when the 
pre-replication complex (pre-RC) is assembled (Fig.4.2.4). Additional RECQ4 is found at 
origins at the G1/S border when CDC6 leaves origins. This suggests that RECQ4 may be 
an integral component of the human pre-initiation (pre-IC) complex. RECQ1, despite its 
presence throughout the cell cycle, is first reliably detected at origins at the onset of the 
S phase when ORC1 is lost and origins are licensed for firing. The amount of origin-
bound RECQ1 and RECQ4 are maximal in early S phase, and by mid-S phase both are lost 
from the early firing human lamin B2 and GM-CSF replication origins. An intriguing 
mechanism for the loss of RECQ1 and RECQ4 from origins is that one or both proteins 
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become associated with active replisomes. Similar ChIP experiments performed in 
budding yeast showed that Sgs1, the RecQ homologue in Saccharomyces cerevisiae, 
interacts with the ARS305 yeast replication origin (Cobb et al., 2003). Interestingly, Sgs1 
associate with ARS sequences at the beginning of the S phase similarly to RECQ1. 
Previous studies suggested that Sgs1 is the functional homologue of BLM and WRN in 
yeast on the basis of the observation that the cellular phenotype of Sgs1 mutant 
resembles the hyper-recombination phenotype of Bloom’s syndrome patient cells and 
telomere defective Werner syndrome patient cells (Myung et al., 2001). However, I did 
not detect WRN and BLM at early replication origins. Thus, it is likely that Sgs1 in yeast 
plays distinct functions that are shared by the five RecQ helicases in humans. In this 
regard, role of Sgs1 in replication may be shared by RECQ1 or RECQ4 in humans as they 
are the only two RecQ helicases able to associate with DNA replication origins in 
unperturbed cells.        
         I did not detect the RECQ5 along with the two other human RecQ helicases, BLM 
and WRN, at early replication origins. However, I found that they interact with DNA 
replication origin upon treatment with the replication inhibitor HU (Fig.4.1.6) consistent 
with the idea that BLM, WRN, and RECQ5 function in S phase in response to replication 
stress to promote fork recovery or repair (Bachrati and Hickson, 2008). Previous reports 
showed both BLM and WRN translocate from PML bodies to the DNA replication sites 
when the cells are stressed with replication insults and DNA fiber assays revealed both 
BLM and WRN are necessary to restart the replication fork after replication stress. In 
line with these experiments, my finding that BLM, WRN, RECQ5 interact with replication 
origins under replication stress indicates that RecQ helicases are essential for the 
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replication machinery to survive against the replication stress generated endogenously 
or exogenously. 
          In addition to BLM, I also found that Rif1 and RMI1 interact with DNA replication 
origins under hydroxyurea induced replication stress conditions (Fig.4.1.7). Biochemical 
and genetic evidence demonstrated that Rif1 and RMI are integral component of the 
BLM complex and are essential for the maintenance of genome stability. Importantly, 
genetic analysis in chicken DT40 cells demonstrated that vertebrate cells lacking Rif1 
and RMI1 have a higher level of SCE (Meetei et al., 2003; Xu et al., 2008; Yin et al., 
2005). More importantly, Rif
-/-
 DT40 cells display cellular sensitivity to replication stress 
and increased accumulation of stalled replication forks (Xu et al., unpublished results). 
These phenotypes are similar to those observed in BLM
-/- 
cells. My data, along with the 
observations of Xu et al., favour a model that BLM in complex with Rif1 and RMI1 play 
an importat role in restarting the stalled replication forks.  
I also investigated the origin-association kinetics of ORC2, RECQ1, and RECQ4 in early 
firing versus late firing origins (Fig.4.2.6). Thus, I found that RECQ1 and RECQ4’s 
association with replication origin is not regulated by replication origin timing. The 
loading of RECQ1 and RECQ4 on late firing β-globin origin in HeLa cell lines follows the 
same trend observed for the early firing lamin B2 origin of HeLa cell lines or for the β-
globin origin of K562 cell lines. However, the interaction of RECQ1 and RECQ4 with the 
β-globin origin in HeLa cells persists until late S when the origin fires suggesting that 
RECQ1 and RECQ4 are required also for late firing origins. Our studies indicate for the 
first time that there are indeed origin-associated loading time differences that may 
control early versus late firing. Similar analyses have been performed for MCM, CDC45p 
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and DNA polymerase α in Saccharomyces cerevisiae. The ChIP experiments performed 
by Aparicio et al., revealed a delay in origin association of CDC45p and DNA polymerase 
α proteins with the late firing ARS 501 origin when compared with the early firing ARS 
305 origin (Aparicio et al., 1999). This appears to contradict with my observation that 
the loading time of RECQ1 and RECQ4 does not change between the early and late 
replication origins. This discrepancy might be explained considering the differences in 
the regulatory processes that control DNA replication in mammals and yeast. My 
experiments suggest a model for the mammalian system according to which replication 
factors assemble on most or all origins during G1/early S, when cyclin-dependent kinase 
levels are permissive, but further signals are necessary to start replicating at a specific 
point in S phase. Although theres is difference in the temporal loading of replication 
proteins between yeast and mammals, the time RECQ1 and RECQ4 remain associated 
with late firing origins is interestingly similar to the time that CDC45p and DNA 
polymerase α remain associated with late ARS501 origins (Aparicio et al., 1999). This 
supports our idea that RECQ1 and RECQ4 are important also for the firing of late 
replication origins. 
          My results suggest that RECQ1 and RECQ4 are integral components of the 
replication complex and play an important role in DNA replication initiation. Consistent 
with this idea, nascent DNA experiments showed that RECQ1-depleted, and even more 
strikingly, RECQ4-depleted, cells have reduced amounts of nascent, newly synthesized 
DNA containing the lamin B2 and GM-CSF Ori1 and Ori2 origin sequences (Fig 4.4.1). This 
replication defect phenotype was also supported by colony forming assays and BrdU 
incorporation experiments (Fig 4.3.1). RECQ1- and RECQ4-depleted cells show reduced 
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proliferation and an elevated G1 fraction. Similar analyses, in which levels of other 
known replication initiation proteins such as ORC2 have been reduced, also led to a 
decrease in proliferation and an elevated G1 fraction (Machida et al., 2005). These 
responses may protect cells from premature S phase entry without the proper number 
of activated replication origins.  
Replication track analyses confirmed these results by showing that RECQ1, and 
especially RECQ4, are required for efficient replication initiation (Fig 4.4.2). In addition, 
RECQ1-depleted cells display shorter replication tracks than control cells, indicating that 
RECQ1, though not RECQ4, might play an additional role in replication fork progression 
in unperturbed cells. Similar DNA fiber analyses previously identified a role for BLM in 
efficient restart of replication forks, and in the suppression of new origin firing after 
DNA damage (Davies et al., 2007; Rao et al., 2007). WRN, in contrast, is not required for 
efficient restart but is required to ensure normal fork progression after recovery from 
HU-mediated arrest (Sidorova et al., 2008). Thus, RECQ1, BLM and WRN may play 
distinct functions in modulating fork activity and fork rate during S-phase.  
My work also establishes new parallels and provides new mechanistic insight 
into the comparative roles of human RECQ4 and X. leavis RECQ4 proteins in replication. 
X. leavis RECQ4 is required to establish active replication forks, and appears to act by 
facilitating the loading of replication factors at origins (Matsuno et al., 2006; Sangrithi et 
al., 2005). The recent demonstration that RECQ4, as well as RECQ1, possess intrinsic 
ATP-dependent helicase activity (Xu and Liu, 2009) suggests that both proteins might 
facilitate replication initiation by promoting origin unwinding with the MCM helicase 
complex. Consistently, a recent study reported that RECQ4 physically interacts with the 
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MCM2-7 replicative complex. This interaction is mediated by MCM10, which regulates 
the helicase activity of RECQ4 possibly to prevent unlicensed replication initiation (Xu et 
al., 2009b). Interestingly, the same authors showed that the MCM10-RECQ4 interaction 
is not shared by other human RecQ helicases, including RECQ1, suggesting that RECQ1 
might interact with a different component of the replication complex. Thus, human 
RECQ4 and RECQ1 recruitment following assembly of the pre-RC might facilitate 
replication initiation in two ways: by origin unwinding, and by the recruitment of 
proteins required to assemble the replisome. Consistent with this idea, Xu and 
collaborators reported that RECQ4 down-regulation does not affect the chromatin 
binding of MCM and CDC6 supporting the notion that RECQ4 loads on the origin 
downstream of these pre-RC complex factors, but affects the chromatin recruitment of 
the GINS complex (Xu et al., 2009b).  This finding was also confirmed by a recent study 
showing that the assembly of the Cdc45-MCM2-7-GINS complex requires RECQ4 and 
MCM10 (Im et al., 2009). Moreover, we found that RECQ4 and RECQ1 are required for 
efficient PCNA loading that precedes and is required for polymerase loading onto the 
replication fork. RECQ4 also facilitates the loading of the ssDNA binding protein RPA, as 
already shown in X.leavis (Sangrithi et al., 2005). Since RPA is likely to act in concert with 
helicases to stabilize unwound replication origins, a lack of RECQ4 helicase activity could 
hamper origin unwinding with the generation of single-stranded DNA as well as RPA and 
PCNA loading onto nascent replication forks. 
Previous studies demonstrated that recombinant human RECQ4 can replace X. 
leavis RECQ4 in DNA replication in egg extracts (Sangrithi et al., 2005), and that deletion 
of the N-terminus of mouse RECQ4 leads to early embryonic lethality (Ichikawa et al., 
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2002). Of note, the N-terminus of X. leavis RECQ4 shares homology with the N-termini 
of the yeast proteins Sld2. These proteins are essential for DNA replication in yeast, but 
do not appear to have readily identifiable, conserved vertebrate homologs (Matsuno et 
al., 2006).  
   
 
Figure  5.1. Schematic structures of Sld2 of Saccharomyces cerevisiae (Sc),  Xenopus laevis (Xl) RecQ4, 
human RecQ4. The N-termini shown in pink and the dashed lines indicate the location of the Sld2 
domains. Proteins interacting with the N-termini are also indicated. 
 
My results support the idea that there may be functional conservation between 
human and Xenopus RECQ4s and these essential yeast proteins during DNA replication 
initiation. Moreover, my finding that RECQ4 has a role in replication initiation, though 
probably not in elongation, provides new insight into the function of this helicase during 
the replication process. The replication function of RECQ4 is likely to be preserved in RTS 
patients since most of the mutations associated with RTS are located in at the centre of 
RECQ4 leaving intact the N-terminal domain of the protein. 
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Cellular functions of RECQ1, in contrast to RECQ4, are not as well-defined. 
Previous studies have shown that acute depletion of RECQ1 affects cellular proliferation 
(Futami et al., 2008; Sharma and Brosh, 2007, 2008). Moreover, RECQ1 depletion 
renders cells sensitive to DNA damage, and leads to spontaneous γ-H2AX foci formation 
as well as elevated levels of sister chromatid exchanges. These results indicate that 
RECQ1 plays an important role in the maintenance of genome stability (Sharma and 
Brosh, 2007). Surprisingly, RECQ1-deficient mice do not show any apparent phenotypic 
difference when compared to wild-type mice, although embryonic fibroblasts derived 
from the RECQ1-deficient mice show hypersensitivity to ionizing radiation and 
spontaneous chromosomal breakage (Sharma et al., 2007). This discrepancy between 
cellular and organismal phenotypes could be explained by functional compensation for 
the loss of RECQ1 during development, as has been reported for proteins such as the 
tumor suppressor pRB (Sage et al., 2003). Alternatively, loss of RECQ1 alone may not 
reveal a phenotype in the absence of additional defects. This has been the case for Wrn-
deficient mice that develop accelerated tumorigenesis only on a p53-minus background 
(Lebel et al., 2001), or an organismal phenotype resembling Werner syndrome with 
features of premature aging only when combined with later generation telomerase 
deficiency (Chang et al., 2004; Du et al., 2004). An additional explanation for the lack of 
an organismal phenotype is that the RECQ1 deficient mice do not carry a complete 
knockout of the RECQ1 gene, but only a deletion of a portion of the gene that includes 
the helicase domain IV and part of helicase domain V. Thus, the RECQ1 region important 
for its replication function might be still expressed in these mice. Likewise, RECQ4 
mouse models carrying deletions or nonsense mutations of the helicase domain are still 
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viable, and only the deletion of the N-terminal domain of the RECQ4 gene leads to 
embryonic lethality (Dietschy et al., 2007; Ichikawa et al., 2002). One potential role for 
RECQ1 in genomic stability assurance was suggested by the recent identification of 
RECQ1 as part of a piRNA complex implicated in transcriptional gene silencing (Lau et al., 
2006). The size, single-stranded nature and strand-specificity of short noncoding piRNAs 
suggest that piRNA generation could occur during DNA replication and thus be 
influenced by RECQ1 or other replication proteins (Bateman and Wu, 2007). Moreover, 
a recent study demonstarted that RECQ1 is an integral component of the replication 
complex required for the Kaposi’s sarcoma-associated herpesvirus replication (Wang et 
al., 2008).  
My results are consistent with these findings, and provide new evidence that 
RECQ1 plays an important role in replication initiation and replication fork progression. 
An intriguing possibility that cannot be excluded at this stage is that RECQ1 might be 
required for the firing of a subset of origins that lack RECQ4. This function could be 
particularly relevant for the firing of dormant origins after DNA replication stress that 
either stalls or slows normal replication forks. RECQ1, together with RECQ4, may also 
play a role in early S phase to stabilize or repair replication forks. This role would be 
consistent with the DNA damage sensitivity of both RECQ1 deficient HeLa cells and 
RECQ4 deficient primary fibroblasts (Jin et al., 2008; Sharma et al., 2007).  
In summary, my work identifies important and distinct roles for two human RecQ 
helicase proteins, RECQ1 and RECQ4, in DNA replication. RECQ4 appears to function 
early, in replication initiation, when pre-replication complex assembly takes place and 
active replisomes are assembled. RECQ1 is also required for efficient replication 
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initiation and might play an additional role during replication elongation. The 
mechanisms by which RECQ1 and RECQ4 participate in replication initiation, and 
whether helicase activities are required in this process, demand further investigation. 
My studies also begin to suggest how the loss of specific human RecQ helicases may 
promote genomic instability and promote tumorigenesis as part of characteristic, 
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VI.    Abbreviations 
 
 
Abbreviation                       Explanation 
ATP                            -           Adenosine Triphosphate  
ADP                            -          Adenosine diphosphate 
NTP                            -          Nucleoside triphosphate 
SF                               -          SuperFamily 
ss DNA                       -          Single stranded DNA 
dsDNA                       -          Double stranded DNA 
AAA
+                                       -               
ATPases associated with various cellular activities 
RQC                            -          RecQ C-terminal domain (RQC) 
HRDC                         -          Helicase RNase D C-terminus 
WH                             -          Winged helix 
NLS                             -          Nuclear localization signals 
WS                              -         Werner Syndrome 
BS                               -          Bloom Syndrome 
RTS                             -          Rothmund- Thomson Syndrome 
BGS                             -         Baller- Gerold syndrome 
BLM                            -         Bloom syndrome protein 
WRN                           -         Werner syndrome protein 
RMI                            -          RecQ mediated genome instability 
FA                               -          Fanconi anaemia 
PML                            -         Promyelocytic leukemia  
RNAPII                       -          RNA polymerase 
MLH                           -          mutL homologue 
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FEN1                          -          Flap structure-specific endonuclease 
SCE                             -          Sister chromatid exchanges 
MEF                            -         Mouse embryonic fibroblast 
ES cells                      -          Embryonic stem cells 
DSB                            -          DNA double-strand break 
SSB                             -          Single strand binding protein 
BER                            -          Base excision repair 
HU                              -          Hydroxyurea 
MMS                          -          Methyl methanesulphonate 
CPT                             -         Camptothecin 
4NQO                        -          4-nitroquinoline-1-oxide 
HR                              -          Homologous recombination 
HJ                               -          Holliday junction 
SUMO-1                    -          Small ubiquitin-related modifier-1; 
TRF                             -          Telomeric repeat binding factor 
PCNA                          -         Proliferating-cell nuclear antigen 
RPA                             -         Replication protein A 
MRN                          -          The MRE11/RAD50/NBS1 complex 
ATM                           -          Ataxia telangiectasia mutated 
RNAi                           -         RNA interference 
siRNA                         -          Small interfering RNA  
IgG                             -          Immunoglobulin G 
bp                               -          Base pairs 
nt                                -         Nucleotides 
UV                              -          Ultraviolet 
ChIP                           -          Chromatin immunoprecipitation 
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BrdU                          -          Bromodeoxyuridine 
CldU                           -          Chlorodeoxyuridine 
IdU                             -          Iododeoxyuridine 
MNase                      -           Micrococal Nuclease 
RF                               -          Replication Fork 
ICL                              -          Interstrand CrossLinks 
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